Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
31-May-14 | Sep. 19, 2014 | Nov. 30, 2013 | |
Document and Entity Information | ' | ' | ' |
Entity Registrant Name | 'SOFTECH INC | ' | ' |
Document Type | '10-K | ' | ' |
Document Period End Date | 31-May-14 | ' | ' |
Amendment Flag | 'false | ' | ' |
Entity Central Index Key | '0000354260 | ' | ' |
Current Fiscal Year End Date | '--05-31 | ' | ' |
Entity Common Stock, Shares Outstanding | ' | 833,724 | ' |
Entity Filer Category | 'Smaller Reporting Company | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Document Fiscal Year Focus | '2014 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Entity Public Float | ' | ' | $1,182,887 |
CONSOLIDATED_CONDENSED_BALANCE
CONSOLIDATED CONDENSED BALANCE SHEETS (in thousands) (USD $) | 31-May-14 | 31-May-13 |
In Thousands, unless otherwise specified | ||
ASSETS | ' | ' |
Cash and cash equivalents | $1,209 | $1,188 |
Restricted cash | ' | 100 |
Accounts receivable (less allowance for uncollectible accounts of $18 and $29 as of May 31, 2014 and 2013, respectively) | 666 | 895 |
Holdback Payment and Earn-Out Payments from CADRA Sale | 547 | ' |
Debt issuance costs, net | 139 | ' |
Prepaid expenses and other assets | 204 | 299 |
Total current assets | 2,765 | 2,482 |
LIABILITIES, REDEEMABLE COMMON STOCK AND SHAREHOLDERS' EQUITY | ' | ' |
Accounts payable | 483 | 137 |
Accrued expenses | 503 | 602 |
Other current liabilities | 104 | 89 |
Deferred maintenance revenue | 1,462 | 2,088 |
Current portion of capital lease | 19 | 13 |
Current portion of long-term debt | 973 | ' |
Total current liabilities | 3,544 | 2,929 |
Shareholders' equity : | ' | ' |
Common stock, $0.10 par value 20,000,000 shares authorized, 825,135 and 995,135 issued and outstanding at May 31, 2014 and 2013, respectively. | 83 | 100 |
Capital in excess of par value | 27,338 | 27,369 |
Accumulated deficit | -26,081 | -25,333 |
Accumulated other comprehensive loss | -482 | -424 |
Total shareholders' equity | $858 | $1,712 |
CONSOLIDATED_CONDENSED_BALANCE1
CONSOLIDATED CONDENSED BALANCE SHEETS PARENTHETICALS (USD $) | 31-May-14 | 31-May-13 |
In Thousands, unless otherwise specified | ||
Parentheticals | ' | ' |
Redeemable common stock shares issued | 50,000 | 50,000 |
Redeemable common stock shares outstanding | 50,000 | 50,000 |
Common Stock, shares authorized | 20,000,000 | 20,000,000 |
Common Stock, shares issued | 825,135 | 995,135 |
Common Stock, shares outstanding | 825,135 | 995,135 |
Accounts receivables allowances uncollectable | $18 | $29 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except for share and per share data) (USD $) | 12 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | 31-May-14 | 31-May-13 |
Revenues {1} | ' | ' |
Products | $1,138 | $1,284 |
Services | 3,861 | 4,784 |
Royalties on sale of patents | 10 | 290 |
Total revenues | 5,009 | 6,358 |
Cost of revenues: | ' | ' |
Products (1) | 366 | 141 |
Services (1) | 1,201 | 1,234 |
Total cost of revenues | 1,567 | 1,375 |
Gross margin | 3,442 | 4,983 |
Research and development expenses | 1,171 | 1,087 |
Selling, general and administrative expenses | 3,465 | 3,186 |
Gain on sale of product line | -649 | ' |
Operating income (loss) | -545 | 710 |
Interest expense | 251 | 342 |
Other income, net | -50 | -7 |
Income (loss) before income taxes | -746 | 375 |
Provision for income taxes | 2 | 15 |
Net income (loss) | ($748) | $360 |
Basic and diluted net income (loss) per share | ($0.85) | $0.35 |
Weighted average common shares outstanding-basic | 876,860 | 1,018,709 |
Weighted average common shares outstanding-diluted | 876,860 | 1,019,812 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)(in thousands) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | 31-May-14 | 31-May-13 |
COMPREHENSIVE INCOME: | ' | ' |
Net income(loss) | ($748) | $360 |
Foreign currency translation adjustment | -58 | 32 |
Total other comprehensive income (expense) | -58 | 32 |
Comprehensive income | ($806) | $392 |
CONSOLIDATED_STATEMENTS_OF_CHA
CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE COMMON STOCK AND EQUITY (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | 31-May-14 | 31-May-13 |
Redeemable common stock: | ' | ' |
Redeemable common stock balance at beginning of year | $275 | $0 |
Issuance of redeemable common stock, net of issuance costs | 0 | 158 |
Accretion of redeemable common stock to redemption value | 0 | 117 |
Redeemable common stock at end of year | 275 | 275 |
Common stock: | ' | ' |
Common Stock balance at beginning of year | 100 | 100 |
Repurchase of common stock | -17 | 0 |
Common Stock balance at end of year | 83 | 100 |
Capital in excess of par value: | ' | ' |
Capital in excess of par value balance at beginning of year | 27,369 | 27,478 |
Repurchase of common stock | -46 | 0 |
Accretion of redeemable common stock to redemption value. | 0 | -117 |
Stock based compensation. | 15 | 8 |
Capital in excess of par value balance at end of year | 27,338 | 27,369 |
Accumulated deficit: | ' | ' |
Accumulated deficit balance beginning of year | -25,333 | -25,693 |
Net income(loss) | -748 | 360 |
Accumulated deficit balance at end of year | -26,081 | -25,333 |
Accumulated other comprehensive loss: | ' | ' |
Accumulated other comprehensive loss balance at beginning of year | -424 | -456 |
Foreign currency translation adjustments | -58 | 32 |
Accumulated other comprehensive loss balance at end of year | -482 | -424 |
Total shareholders' equity at end of year | $858 | $1,712 |
Outstanding shares: | ' | ' |
Balance of redeemable common stock at beginning of year | 50,000 | 0 |
Issuance of redeemable common stock | 0 | 50,000 |
Balance of redeemable common stock at end of year | 50,000 | 50,000 |
Balance of common stock at beginning of year | 995,135 | 995,135 |
Repurchase of common stock. | -170,000 | 0 |
Balance of common stock at end of year | 825,135 | 995,135 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | 31-May-14 | 31-May-13 |
Cash flows from operating activities: | ' | ' |
Net income (loss) | ($748) | $360 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ' | ' |
Depreciation and amortization expense | 294 | 333 |
Gain on sale of product line | -649 | ' |
Change in fair value of Holdback Payment and Earn-Out Payments | -17 | ' |
Stock-based compensation | 15 | 8 |
Non-cash interest expense | 24 | ' |
Change in fair value of warrant liability | -32 | ' |
Changes in current assets and liabilities: | ' | ' |
Accounts receivable | 229 | -138 |
Prepaid expenses and other current assets | 95 | -55 |
Accounts payable, accrued expenses and other liabilities | 351 | 52 |
Deferred maintenance revenue | -78 | -47 |
Net cash provided by (used in) operating activities | -516 | 513 |
Cash flows from investing activities: | ' | ' |
Proceeds from sale of product line, net of direct cash expenses | 2,432 | ' |
Capital expenditures | -39 | -2 |
Capitalized software development costs | -57 | -276 |
Capitalized patent costs | -5 | -19 |
Net cash provided by (used in) investing activities | 2,331 | -297 |
Cash flows from financing activities: | ' | ' |
Proceeds from issuance of redeemable common stock, net of expenses | ' | 223 |
Cost of repurchasing common stock | -63 | ' |
Borrowings under Loan Agreement | ' | 2,700 |
Borrowings under Credit Facility | ' | 300 |
Repayment under Loan Agreement and Credit Facility | -1,700 | -2,500 |
Repurchase of warrant liability | -19 | ' |
Capitalized debt issuance costs | -32 | -255 |
Repayments under capital lease | -16 | -10 |
Net cash provided by (used in) financing activities | -1,830 | 458 |
Effect of exchange rates on cash | -64 | 19 |
Increase (decrease) in cash and cash equivalents | -79 | 693 |
Cash and cash equivalents, beginning of period | 1,288 | 595 |
Cash and cash equivalents, end of period | 1,209 | 1,288 |
Supplemental disclosures of cash flow information: | ' | ' |
Interest paid | 240 | 157 |
Income taxes paid | 14 | 2 |
Supplemental disclosures of non-cash investing and financing activities: | ' | ' |
Issuance of warrants | 51 | ' |
Purchase of property and equipment under capital lease | 30 | 53 |
Accretion of redeemable common stock | ' | $117 |
Description_of_the_Business_an
Description of the Business and Basis of Presentation | 12 Months Ended |
31-May-14 | |
Description of the Business and Basis of Presentation | ' |
Description of the Business and Basis of Presentation | ' |
A. DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION | |
SofTech, Inc. (the “Company”) was formed in Massachusetts on June 10, 1969. The Company is engaged in the development, marketing, distribution and support of computer software solutions that serve the Product Lifecycle Management (“PLM”) industry. the Company’s operations are organized geographically with offices in the U.S. and European sales and customer support offices in Germany and Italy. The Company also has resellers in Asia and Europe. | |
Since the Recapitalization Transaction described hereunder, the Company has also been actively engaged in acquiring and filing new U.S. patents, evaluating alternatives for monetizing its existing patents and investigating the acquisition of specific patents already awarded that might enhance shareholder value. It is expected that this kind of activity will become an increasing area of focus and investment over the coming years. | |
The consolidated financial statements of the Company include the accounts of SofTech, Inc. and its wholly-owned subsidiaries, Information Decisions, Inc., Workgroup Technology Corporation, SofTech, GmbH and SofTech, Srl. All significant intercompany accounts and transactions have been eliminated in consolidation. | |
CADRA Sale | |
On October 18, 2013, the Company sold substantially all of the assets of its CADRA product line, including all intellectual property related to that technology but specifically excluding cash, billed accounts receivable and liabilities other than the deferred maintenance liability associated with CADRA customer maintenance contracts for support services (the “CADRA Sale”), to Mentor Graphics Corporation (“Mentor”), pursuant to an Asset Purchase Agreement dated August 30, 2013 (the “Asset Purchase Agreement”). The aggregate consideration for the CADRA Sale is up to $3.95 million, which is comprised of (i) $2.88 million of which was paid on the closing date; (ii) $320,000 of which will be paid on the one year anniversary (the “Holdback Payment”) of the closing date (subject to any indemnification claims); and (iii) up to an aggregate $750,000 over the three-year period subsequent to the closing date, based on 10% of the net revenue generated by the CADRA business (the “Earn-Out Payments”), subject to the terms of the Earn-Out Agreement dated August 30, 2013 (the “Earn-Out Agreement”). | |
The Company will continue to offer the CADRA technology as a reseller throughout Europe (except Germany) on an exclusive basis until October 18, 2014 pursuant to a distribution agreement with Mentor (“Distributorship Agreement”) at which time the Distributorship Agreement will be subject to renewal by mutual agreement of the parties. In addition, for a one year period from the closing of the transaction the Company retained the right to market the CADRA technology to Sikorsky Aircraft, the largest CADRA user in the United States. Due to the significant continued involvement in the sale and support of the CADRA product line, the transaction does not qualify for presentation as discontinued operations. | |
Recapitalization Transaction | |
In March 2011, the current management team (CEO and VP of Business Development) completed a transaction (the “Recapitalization Transaction”) in which a group of eight investors purchased 39% of the Company’s common stock, arranged for debt facilities of $3.2 million and negotiated for a $7.6 million debt reduction from Greenleaf Capital, Inc. (“Greenleaf”), at that time, the Company’s sole lender and largest shareholder. As part of that Recapitalization Transaction, Greenleaf accepted a payment of $2.7 million in cash and a note for $250,000 in full satisfaction of the $10.6 million of indebtedness. The $250,000 note was repaid in its entirety during fiscal year 2013. The former CEO resigned after a short transition period, a new four person Board of Directors was appointed and the existing Board members resigned. In addition, Greenleaf gave the Company’s new Board of Directors voting control over its shares for a three year period immediately following the Recapitalization Transaction. The Company subsequently repurchased all 271,411 shares of its common stock owned by Greenleaf and Greenleaf related parties as described hereunder. | |
Refinancing of Debt | |
On December 5, 2013, the Company entered into an amended and restated loan agreement (the “Amended Loan Agreement No. 2”) between the Company, and Prides Crossing Capital Funding, L.P., (the “Lender”) whereby the parties agreed to amend and restate the Company’s existing $2.7 million Loan Agreement, as defined in Note F, following the CADRA Sale. The Lender was the successor to Prides Crossing Capital, L.P. and Prides Crossing Capital-A, L.P., the Lenders, as defined in Note F, under the Loan Agreement. Under the terms of the Amended Loan Agreement No. 2, the Company agreed to pay down the principal of the Loan Agreement from $2.7 million to $1.0 million (the “Term Note”) using a portion of the proceeds from the CADRA Sale. In addition, the Company paid a pre-payment penalty of $81,000 and agreed to repurchase the outstanding warrants to purchase 25,000 shares of common stock at an exercise price of $1.00 per share in exchange for $19,000. | |
The amended and restated Term Note matures on January 1, 2015 and bears an interest rate of 14% payable in arrears on a monthly basis throughout the life of the loan. The Term Note may be repaid in full at any time but partial voluntary pre-payments are not allowed. If a pre-payment is made on or prior to September 30, 2014, the Company shall pay a yield maintenance fee equal to the interest that would have accrued under the Term Note from the date of pre-payment through September 30, 2014. No yield maintenance fee is due for a pre-payment made subsequent to September 30, 2014. | |
Stock Purchase Agreement with Greenleaf Capital and Affiliates | |
In June 2013, the Company purchased 170,000 shares of common stock from Greenleaf, The Ronda E. Stryker and William D. Johnston Foundation, and The L. Lee Stryker 1974 Irrevocable Trust fbo Ronda E. Stryker, for a purchase price of $62,900 or $0.37 per share as detailed in Note K to the Company’s Annual Report on Form 10-K for the fiscal year ended May 31, 2013. The agreement provides an option for the Company to either make an offer to purchase the remaining 101,411 shares held by Greenleaf at $0.37 per share or to provide Greenleaf with registration rights with respect to the remaining shares as set forth in the Registration Rights Agreement dated March 8, 2011. On August 8, 2014 the Company repurchased Greenleaf’s remaining 101,411 shares at $0.37 per share for a total of approximately $37,000. | |
Liquidity and Subsequent Financing Events | |
The Company operated at a net loss during the fiscal year ended May 31, 2014 and used $516,000 of cash in its operations. As detailed in Note M, subsequent to fiscal year end, the Company entered into a three-year, $750,000 promissory note, a six-month $300,000 term note and issued 160,000 shares of its common stock at $5.00 per share in private placements with four accredited investors raising an additional $800,000. These funds are expected to be used to pay down the Company’s $1 million debt that is due on January 1, 2015 and to provide working capital. Based upon current cash levels, the aforementioned financing events and the operating outlook for fiscal 2015, the Company anticipates that its cash resources will be sufficient to fund operations for at least the next twelve months. | |
Significant_Accounting_Policie
Significant Accounting Policies | 12 Months Ended | ||||||||
31-May-14 | |||||||||
Significant Accounting Policies | ' | ||||||||
Significant Accounting Policies | ' | ||||||||
B. SIGNIFICANT ACCOUNTING POLICIES | |||||||||
USE OF ESTIMATES | |||||||||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, the allowance for doubtful accounts receivable, the fair value estimate of the Holdback Payment and Earn-Out Payments due from Mentor related to the sale of the CADRA business and the valuation of long term assets including goodwill, capitalized patent costs, capitalized software development costs and deferred tax assets. Actual results could differ from those estimates. | |||||||||
CASH AND CASH EQUIVALENTS | |||||||||
The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains cash at certain financial institutions in amounts that at times, exceed Federal Deposit Insurance Corporation limits. Cash held in foreign bank accounts at May 31, 2014 totaled approximately $182,000. The Company does not believe it is exposed to significant credit risk related to cash and cash equivalents. | |||||||||
CONCENTRATION OF CREDIT RISK | |||||||||
The Company believes that the loss of one or more of our largest customers could have a material adverse effect on the business. During fiscal years 2014 and 2013, no customer exceeded ten percent of revenue. The Company generally does not require collateral on credit sales. Management evaluates the creditworthiness of customers prior to delivery of products and services and provides allowances at levels estimated to be adequate to cover any potentially uncollectible accounts. Bad debts are written off against the allowance when identified. The changes in the accounts receivable reserve are as follows (in thousands): | |||||||||
For the Years Ended May 31, | Balance, Beginning of Period | Charged to Costs and Expenses | Bad Debt Write-offs | Balance, End of Period | |||||
2013 | $ | 29 | $ | - | $ | - | $ | 29 | |
2014 | $ | 29 | $ | 44 | $ | 55 | $ | 18 | |
PROPERTY AND EQUIPMENT | |||||||||
Property and equipment is stated at cost. The Company provides for depreciation on a straight-line basis over the following estimated useful lives: | |||||||||
Data Processing Equipment | 2-5 years | ||||||||
Office furniture | 5-10 years | ||||||||
Automobiles | 4-6 years | ||||||||
Depreciation expense, including amortization of assets under capital lease, was approximately $37,000 and $35,000, for fiscal years 2014 and 2013, respectively. | |||||||||
Maintenance and repairs are charged to expense as incurred; betterments are capitalized. At the time property and equipment are retired, sold, or otherwise disposed of, the related costs and accumulated depreciation are removed from the accounts. Any resulting gain or loss on disposal is credited or charged to income. | |||||||||
SOFTWARE DEVELOPMENT COSTS | |||||||||
The Company accounts for its software development costs in accordance with Accounting Standards Codification (“ASC”) 985, Costs of Computer Software to Be Sold, Leased or Marketed. Costs that are incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, software development costs are capitalized until the product is available for general release to customers. Such costs are amortized using the straight-line method over the estimated economic life of the product, generally three years. The Company evaluates the realizability of the assets and the related periods of amortization on a regular basis. Judgment is required in determining when technological feasibility of a product is established as well as its economic life. | |||||||||
During fiscal years 2014 and 2013, the Company capitalized approximately $57,000 and $276,000, respectively, of software development costs. Amortization expense related to capitalized software development costs for fiscal years 2014 and 2013 was approximately $114,000 and $73,000, respectively. | |||||||||
DEBT ISSUANCE COSTS | |||||||||
The Company capitalizes the direct costs associated with entering into debt agreements and amortizes those costs over the life of the debt agreement. In May 2013, the Company entered into the Loan Agreement as detailed in Note F. Total direct costs incurred in establishing this debt agreement were approximately $255,000 which are being amortized over the term of the arrangement in accordance with ASC 470-50. During the fiscal year ending 2014, the Company capitalized approximately $31,000 of debt issuance costs related to the Loan Agreement. Unamortized debt issuance costs related to the prior credit facility totaled approximately $108,000 and were expensed in Q4 of fiscal 2013. Amortization expense related to debt issuance costs for fiscal years 2014 and 2013 was approximately $143,000 and $225,000, respectively. | |||||||||
Amended Loan Agreement No. 2 described in Note F hereunder was a modification per ASC 470-50, Debt Modifications and Extinguishment, therefore the direct costs totaling approximately $120,000 incurred in completing the modification were expensed. | |||||||||
INCOME TAXES | |||||||||
The provision for income taxes is based on the earnings or losses reported in the consolidated financial statements. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The Company provides a valuation allowance against deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. | |||||||||
The Company recognizes the tax benefit from an uncertain tax position only if it more-likely-than-not that the tax position will be sustained upon examination by taxing authorities, based on technical merits of the tax position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, changes in the tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, and changes in facts or circumstances related to a tax position. Any changes to these estimates, based on the actual results obtained and/or a change in assumptions, could impact the Company’s tax provision in future periods. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for federal and state income taxes. In accordance with the applicable statute of limitations, the Company’s tax returns could be audited by the Internal Revenue Service and various states for the fiscal years ended 2011 to 2013. | |||||||||
REVENUE RECOGNITION | |||||||||
The Company follows the provisions of ASC 985, Software, for transactions involving the licensing of software and software support services. Revenue from software license sales is recognized when persuasive evidence of an arrangement exists, delivery of the product has been made, and a fixed fee and collectability has been determined. The Company does not provide for a right of return. For multiple element arrangements, total fees are allocated to each of the undelivered elements based upon vendor specific objective evidence (“VSOE”) of their fair values, with the residual amount recognized as revenue for the delivered elements, using the residual method set forth in ASC 985. Revenue from customer maintenance support agreements is deferred and recognized ratably over the term of the agreements, typically one year. Revenue from engineering, consulting and training services is recognized as those services are rendered using a proportional performance model. | |||||||||
The Company follows the provisions of ASC 605, Revenue Recognition for transactions that do not involve the licensing of software or software support services as in the case of the recent sale of its patents. Revenue from the sale of patents is recorded when persuasive evidence of an arrangement exists, delivery has taken place and a fixed fee and collectability has been determined. These conditions are no different from those when the Company licenses software. For multiple element arrangements, however, under ASC 605, total fees are allocated to each of the elements based upon the relative selling price method. Under that method the allocation of fees to the undelivered elements is based on VSOE, or if it doesn’t exist, then based on third party evidence of selling price. If neither exists, then the allocation is based on management’s best estimate of the selling price. | |||||||||
PATENT COSTS | |||||||||
Costs related to patent applications are capitalized as incurred and are amortized once the patent application is accepted or are expensed if the application is finally rejected. Patent costs are amortized over their estimated economic lives under the straight-line method, and are evaluated for impairment when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable through the estimated undiscounted future cash flows from the use of the associated patent. Capitalized patent costs totaled approximately $6,000 and $19,000 for the years ending May 31, 2014 and 2013, respectively. | |||||||||
ACCOUNTING FOR GOODWILL | |||||||||
The Company accounts for goodwill pursuant to ASC 350, Intangibles – Goodwill and Other. This requires that goodwill be reviewed annually, or more frequently as a result of an event or change in circumstances, for possible impairment with impaired assets written down to fair value. Additionally, existing goodwill and intangible assets must be assessed and classified within the statement’s criteria. | |||||||||
During fiscal year 2014, the Company completed the CADRA Sale as described above. The Company attributed a portion of its total goodwill to the CADRA product line and expensed it in the derivation of the gain on the sale. The portion of the total goodwill apportioned to the CADRA product line was equal to the estimated market value of the CADRA product line as compared to the total market value of the Company. | |||||||||
As of May 31, 2014, the Company conducted its annual impairment test of goodwill by comparing the fair value of the reporting unit to the carrying amount of the underlying assets and liabilities of its single reporting unit. The Company determined that the fair value of the reporting unit exceeded the carrying amount of the assets and liabilities, therefore no impairment existed as of the testing date. | |||||||||
LONG-LIVED ASSETS | |||||||||
The Company periodically reviews the carrying value of all intangible and other long-lived assets. If indicators of impairment exist, the Company compares the undiscounted cash flows estimated to be generated by those assets over their estimated economic life to the related carrying value of those assets to determine if the assets are impaired. If the carrying value of the asset is greater than the estimated undiscounted cash flows, the carrying value of the assets would be decreased to their fair value through a charge to operations. As of May 31, 2014, the Company does not have any long-lived assets it considers to be impaired. | |||||||||
FINANCIAL INSTRUMENTS | |||||||||
The Company’s financial instruments consist of cash, restricted cash, accounts receivable, Holdback Payment, Earn-Out Payments, notes receivable, accounts payable, notes payable. The Company’s estimate of the fair value of these financial instruments approximates their carrying amounts at May 31, 2014. The Company sells its products to a wide variety of customers in numerous industries. A large portion of the Company’s revenue is derived from customers with which the Company has an existing relationship and established credit history. For new customers for whom the Company does not have an established credit history, the Company performs evaluations of the customer’s credit worthiness prior to accepting an order. The Company does not require collateral or other security to support customer receivables. The Company’s allowance for uncollectible accounts was approximately $18,000 and $29,000 at May 31, 2014 and 2013, respectively. | |||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | |||||||||
Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company is required to classify certain assets based on the fair value hierarchy, which groups fair value-measured assets based upon the following levels of inputs: | |||||||||
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; | |||||||||
Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; | |||||||||
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). | |||||||||
The assets maintained by the Company that are required to be measured at fair value on a recurring basis include the Holdback Payment and Earn-Out Payments associated with the Company’s sale of the CADRA product line. | |||||||||
The following table summarizes the valuation of the Company's assets and liabilities measured at fair value on a recurring basis as of May 31, 2014: | |||||||||
(in thousands) | |||||||||
Total | Quoted prices in active markets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | ||||||
Assets: | |||||||||
Holdback Payment and Earn-Out Payments | $ | 895 | $ | - | $ | - | $ | 895 | |
Total assets at fair value | $ | 895 | $ | - | $ | - | $ | 895 | |
The Holdback Payment and Earn-Out Payments are classified as current or non-current assets depending on their anticipated distributions to the Company. | |||||||||
The table below provides a summary of the changes in fair value of the Level 3 classified Holdback Payment and Earn-Out Payments asset for the year ended May 31, 2014: | |||||||||
(in thousands) | |||||||||
Contingent Consideration for the Year Ended May 31, 2014 | |||||||||
Fair value at inception | $ | 922 | |||||||
Payments received | -44 | ||||||||
Change in fair value | 17 | ||||||||
Fair value at end of period | $ | 895 | |||||||
The fair value of the asset at May 31, 2014 was approximately $895,000. The fair value of the Holdback Payment and the Earn-Out Payments expected to be collected in fiscal 2015 have been classified as current assets. The fair value of the payments expected to be received beyond fiscal 2015 are included in long term assets in the accompanying consolidated balance sheet. The Company has estimated the fair value of the Holdback Payment and Earn-Out Payments using a discounted cash flow approach. This valuation is based upon several factors including; i) management’s estimate of the amount and timing of future CADRA revenues, ii) the timing of receipt of payments from Mentor, and iii) a discount rate of 7%. | |||||||||
A change in any of these unobservable inputs can significantly change the fair value of the asset. The change in fair value of the asset recognized in the Consolidated Statements of Operations for the year ended May 31, 2014 was approximately $17,000. | |||||||||
CHANGE IN ACCOUNTING POLICY | |||||||||
In our quarterly reports for the fiscal quarters ended November 30, 2013 and February 28, 2014, we accounted for the Holdback Payment and the Earn-Out Payments pursuant to ASC 450, Contingencies whereby the Company recorded a gain of approximately $155,000 through the nine months ended February 28, 2014 which included consideration of the Holdback Payment and reported Earn-Out Payments, but excluded consideration of up to $686,000 of potential future Earn-Out Payments. | |||||||||
During the fourth quarter of fiscal 2014, we changed our accounting policy with regard to these payments to account for the proceeds at the fair value of the consideration received in accordance with ASC 810-10-40-5. Pursuant to the new policy, the Company estimated the fair value of Holdback Payment and the Earn-Out Payments on the date of the transaction and recognized the fair value as a component of the gain on sale as of the transaction date. The Holdback Payment and Earn-Out Payments will be adjusted to fair value at each reporting period with changes in the fair value of the asset reported as a component of other income or expense, net. | |||||||||
Under the new accounting policy, the Company recorded a $649,000 gain on the CADRA Sale during the year ended May 31, 2014, which included the estimated fair value of the Holdback Payment and the Earn-Out Payments of $922,000 on the date of the transaction. Under the ASC 450 the reported gain would have been $197,000 for the year ended May 31, 2014, which would have included $427,000 of Holdback Payment and Earn-Out Payments, that being the amount of the Earn-Out Payments actually reported by Mentor through fiscal year end. This change in accounting policy resulted in a $0.52 decrease in loss per share for the year ended May 31, 2014. There was no impact of the change in accounting policy on previous fiscal years as the Company has not had sale transactions that included earn out agreements in the past. | |||||||||
The Company determined that accounting for the Holdback Payment and the Earn-Out Payments at fair value resulted in a more complete and accurate reflection of the economic value associated with the sale of the CADRA business. The Company considered, among other things, the following facts and circumstances related to the Holdback Payment and the Earn-Out Payments in the decision to change its accounting policy: | |||||||||
· The Holdback Payment and the Earn-Out Payments were earned upon completion of the CADRA Sale; the Company had no further obligation to perform any services to be entitled to receive them; | |||||||||
· The Earn-Out Payments cannot exceed $750,000 and are based on a percentage of revenue, a predictable measure of performance; | |||||||||
· The Company’s continued involvement as a distributor of the CADRA technology throughout most of Europe affords us significant insight into Mentor’s product plans, pricing, upgrade release schedule, continued investment and ongoing strategy with regard to the technology; | |||||||||
· Mentor’s obligation to report the CADRA revenue on a quarterly basis aids in our understanding of their progress against previously prepared forecasts and historical revenue trends; and | |||||||||
· The majority of the CADRA revenue is composed of recurring annual maintenance contracts with a high renewal rate from long-time users of the technology. As such, the revenue over the term of the Earn-Out Agreement is predictable. | |||||||||
The Company concluded that deferring the recognition of the Earn-Out Payments until reported by Mentor under ASC 450 did not accurately and completely reflect the economic value of the sale of the CADRA business that was completed during fiscal year 2014. ASC 810-10-40-5 supports recognizing the fair value of contingent consideration upon the deconsolidation of a subsidiary and the Company believes that electing the accounting policy more accurately and completely depicts the results of operations for the fiscal year ended May 31, 2014 and the financial position as of that date and is therefore preferable. | |||||||||
FOREIGN CURRENCY TRANSLATION | |||||||||
The functional currency of the Company’s foreign operations (Germany, and Italy) is the Euro. As a result, assets and liabilities are translated at period-end exchange rates and revenues and expenses are translated at the average exchange rates. Adjustments resulting from translation of such financial statements are classified in accumulated other comprehensive income (loss). Foreign currency gains and losses arising from transactions were included in operations in fiscal year 2014 and 2013. In fiscal year 2014 and 2013, the Company recorded a net gain from foreign currency related transactions of approximately $(33,000) and $(7,000), respectively, to Other income, net in the Consolidated Statements of Operations. | |||||||||
COMPREHENSIVE INCOME (LOSS) | |||||||||
Comprehensive income (loss) is a more inclusive reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income (loss). To date, the Company’s comprehensive income items include only foreign translation adjustments. Comprehensive income (loss) has been included in the Consolidated Statements of Comprehensive Income (Loss) for all periods. | |||||||||
NET INCOME (LOSS) PER COMMON SHARE | |||||||||
Basic net income (loss) per share are computed by dividing the net income (loss) by the weighted-average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted-average number of common and equivalent dilutive common shares outstanding. For periods in which losses are reported potentially dilutive common stock equivalents are excluded from the calculation of diluted loss per share because the effect is anti-dilutive. | |||||||||
The following table details the derivation of weighted average shares outstanding used in the calculation of basic and diluted net income (loss) for each period: | |||||||||
(Amounts in thousands, except share amounts) | |||||||||
Years Ended | |||||||||
May 31, | May 31, | ||||||||
2014 | 2013 | ||||||||
Net income (loss) available to common shareholders | $ | -748 | $ | 360 | |||||
Weighted average number of common shares outstanding used in calculating basic earnings per share | 876,860 | 1,018,709 | |||||||
Weighted average number of common shares outstanding used in calculating diluted earnings per share | 876,860 | 1,019,812 | |||||||
For the fiscal year ending May 31, 2014, 129,500 options to purchase common shares were anti-dilutive and were excluded from the above calculation. | |||||||||
STOCK-BASED COMPENSATION | |||||||||
Stock-based compensation expense for all stock-based payment awards made to employees and directors is measured based on the grant-date fair value of the award. The Company estimated the fair value of each share-based award using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions as to stock price volatility, the expected life of options, a risk-free interest rate and dividend yield. The Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period of the award. | |||||||||
In May 2011, the 2011 Equity Incentive Plan (the “2011 Plan”) was approved by the Company’s shareholders, pursuant to which 150,000 shares of our common shares are reserved for issuance. Any shares subject to any award under the 2011 Plan that expires, is terminated unexercised or is forfeited will be available for awards under the 2011 Plan. The Company may grant stock options, restricted stock, restricted stock units, stock equivalents and awards of shares of common stock that are not subject to restrictions or forfeiture under the 2011 Plan. As of May 31, 2014, 129,500 options were awarded. | |||||||||
The following table summarizes option activity under the 1994 and the 2011 Stock Option Plan: | |||||||||
Number of Options | Weighted Average Exercise Price Per Share | Weighted-Average Remaining Life (in years) | Aggregate Intrinsic Value | ||||||
Outstanding options at May 31, 2012 | 10,000 | 2.4 | 9.02 | - | |||||
Granted | - | - | - | - | |||||
Exercised | - | - | - | - | |||||
Forfeited or expired | - | - | - | - | |||||
Outstanding options at May 31, 2013 | 10,000 | 2.4 | 8.02 | - | |||||
Granted | 124,500 | 1.84 | 10 | - | |||||
Exercised | - | - | - | - | |||||
Forfeited or expired | -5,000 | 1.11 | - | - | |||||
Outstanding options at May 31, 2014 | 129,500 | $ | 1.88 | 9.74 | $ | 20,825 | |||
Exercisable at May 31, 2014 | 10,493 | $ | 2.17 | 8.49 | $ | 868 | |||
The Company determined the volatility for options granted during the fiscal year ended May 31, 2014 and 2013 using the historical volatility of the Company’s common stock. The expected life of options has been determined utilizing the “simplified” method as prescribed in ASC 718 Compensation, Stock Compensation. The expected life represents an estimate of the time options are expected to remain outstanding. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. The Company has not paid, and does not anticipate paying, cash dividends on its common stock; therefore, the expected dividend yield is assumed to be zero. | |||||||||
For the years ended May 31, 2014 and 2013, the Company expensed approximately $15,000 and $8,000, respectively, of stock-based compensation. The Company had approximately $207,000 of unrecorded stock-based compensation as of May 31, 2014 which will be recognized as expense over the next 2.6 years. | |||||||||
The weighted-average fair value of each option granted in the fiscal year ended May 31, 2014 is estimated as $1.73 on the date of grant using the Black-Scholes model with the following weighted average assumptions: | |||||||||
Expected life | 5.52-5.77 years | ||||||||
Assumed annual dividend growth rate | 0% | ||||||||
Expected volatility | 155% | ||||||||
Risk free interest rate | 1.46-1.96% | ||||||||
The weighted-average fair value of each option granted in the fiscal year ended May 31, 2013 is estimated as $3.32 on the date of grant using the Black-Scholes model with the following weighted average assumptions: | |||||||||
Expected life | 5.77 years | ||||||||
Assumed annual dividend growth rate | 0% | ||||||||
Expected volatility | 188% | ||||||||
Risk free interest rate | 0.95% | ||||||||
REDEEMABLE COMMON STOCK | |||||||||
During the year ending May 31, 2013, the Company issued 50,000 shares of common stock, $0.10 par value (the “Common Stock”) at a purchase price of $5.00 per share to accredited investors (collectively, the “Investors”) in separate private placement transactions for total proceeds of $250,000. These transactions were completed pursuant to a Securities Purchase Agreement (the “Agreement”) which the Company entered into with each of the respective Investors. In lieu of registration rights, each $25,000 investment entitled the Investors to a fee of $6,000 (the “Fee”) to be paid in six equal quarterly installments during the eighteen month period (the “Payment Period”) following the investment. The Agreement also provided the Investors with the right to require the Company to redeem the Common Stock held by such Investors (the “Put Option”) for $5.50 per share in cash for a 30 day period following the Payment Period. | |||||||||
The Company first assessed the redeemable Common Stock to determine if the instrument should be accounted for as a liability in accordance with ASC 480, Distinguishing Liabilities from Equity. In that the Put Option is optionally redeemable by the holder, the Common Stock was not required to be accounted for as a liability. Next, the Company assessed the Put Option within the redeemable Common Stock as a potential embedded derivative pursuant to the provisions of ASC 815, Derivatives and Hedging, and concluded that the Put Option did not meet the net settlement criteria within the definition of a derivative. Therefore, the Company has accounted for the Common Stock issued pursuant to the Agreement in accordance with ASC 480-10-S99-3A, Classification and Measurement of Redeemable Securities, which provides that securities that are optionally redeemable by the holder for cash or other assets are classified outside of permanent equity in temporary equity. The 50,000 shares of Common Stock issued pursuant to the Agreement were recorded as redeemable common stock at an initial carrying value of $163,000. This amount is equal to the gross proceeds of $250,000, less $27,000 in issuance costs related to legal fees and the $60,000 related to the total Fee due to each of the Investors, which has been included in other liabilities. The Company elected to record the Common Stock at its redemption value of $275,000 immediately and accordingly recorded accretion of $112,000 to additional paid in capital during fiscal year 2013. | |||||||||
Subsequent to fiscal year end, each of the Investors exercised their Put Option and the Shares were repurchased by the Company at the agreed upon Put Option price of $5.50 per share for a total of $275,000. | |||||||||
RECENT ACCOUNTING PRONOUNCEMENTS | |||||||||
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, (Topic 606). The ASU is the result of a joint project by the FASB and the International Accounting Standards Board (“IASB”) to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that would: remove inconsistencies and weaknesses, provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices across entities, jurisdictions, industries, and capital markets, improve disclosure requirements and resulting financial statements, and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2016. Early application is not permitted. The Company is currently assessing the impact of this guidance. |
INCOME_TAXES
INCOME TAXES | 12 Months Ended | ||||
31-May-14 | |||||
INCOME TAXES | ' | ||||
INCOME TAXES | ' | ||||
C. INCOME TAXES | |||||
The provision for income taxes includes the following for the years ended May 31 (in thousands): | |||||
2014 | 2013 | ||||
Federal | $ | - | $ | - | |
Foreign | - | 13 | |||
State and local | 2 | 2 | |||
Total current provision | 2 | 15 | |||
Deferred provision | 268 | 148 | |||
Valuation allowance | -268 | -148 | |||
Total deferred provision | - | - | |||
Total provision | $ | 2 | $ | 15 | |
The domestic and foreign components of income (loss) before income taxes were as follows for the years ended May 31 (in thousands): | |||||
2014 | 2013 | ||||
Domestic | $ | -562 | $ | 343 | |
Foreign | -184 | 32 | |||
$ | -746 | $ | 375 | ||
At May 31, 2014, the Company had Federal net operating loss carryforwards of $20 million that begin expiring in 2022, and are available to reduce future taxable income. The utilization of the remaining net operating loss carryforwards may be subject to limitation based on past and future changes in ownership of the Company pursuant to Internal Revenue Code Section 382. The Company also has an alternative minimum tax credit of approximately $200,000 that has no expiration date that was available as of May 31, 2014. | |||||
The Company’s effective income tax rates can be reconciled to the federal and state statutory income tax rate for the years ended May 31 as follows: | |||||
2014 | 2013 | ||||
Federal statutory rate | 34% | 34% | |||
State | - | - | |||
Foreign | - | 1 | |||
Permanent items | - | - | |||
Valuation reserve | -34 | -34 | |||
Effective tax rate | - | 1% | |||
Deferred tax assets (liabilities) were comprised of the following at May 31 (in thousands): | |||||
2014 | 2013 | ||||
Deferred tax assets | |||||
Net operating loss carryforwards | $ | 7,271 | $ | 7,190 | |
Tax credit carryforwards | 254 | 254 | |||
Receivables allowances | 7 | 11 | |||
Vacation pay accrual | 9 | 10 | |||
Other accruals | - | - | |||
Depreciation | 37 | 35 | |||
Differences in book and tax basis of assets of acquired businesses | -859 | -1,050 | |||
Total gross deferred tax assets | 6,719 | 6,450 | |||
Valuation allowance | -6,719 | -6,450 | |||
Net deferred tax asset | $ | - | $ | - | |
Due to the uncertainties regarding the realization of certain favorable tax attributes in future tax returns, the Company has established a valuation reserve against the otherwise recognizable net deferred tax assets. | |||||
EMPLOYEE_RETIREMENT_PLANS
EMPLOYEE RETIREMENT PLANS | 12 Months Ended |
31-May-14 | |
EMPLOYEE RETIREMENT PLANS: | ' |
EMPLOYEE RETIREMENT PLANS | ' |
D. EMPLOYEE RETIREMENT PLANS | |
The Company has an Internal Revenue Code Section 401(k) plan covering substantially all U.S. based employees and offers an employer match of a portion of an employee’s voluntary contributions. The aggregate expense related to this employer match for fiscal years 2014 and 2013 was approximately $51,000 and $46,000, respectively. | |
Segment_Information
Segment Information | 12 Months Ended | ||||
31-May-14 | |||||
Segment Information | ' | ||||
Segment Information | ' | ||||
E. SEGMENT INFORMATION | |||||
The Company operates in one reportable segment and is engaged in the development, marketing, distribution and support of computer aided design and product data management and collaboration computer solutions. The Company’s operations are organized geographically with offices in the U.S. and foreign offices in Germany and Italy. Components of revenue and long-lived assets (consisting primarily of intangible assets, capitalized software and property, plant and equipment) by geographic location, are as follows (in thousands): | |||||
Years Ended | |||||
Revenue: | 31-May-14 | 31-May-13 | |||
North America | $ | 3,593 | $ | 4,596 | |
Asia | 493 | 603 | |||
Europe | 1,557 | 1,771 | |||
Eliminations | -634 | -612 | |||
Consolidated Total | $ | 5,009 | $ | 6,358 | |
Long-Lived Assets: | As of May 31, 2014 | As of May 31, 2013 | |||
North America | $ | 1,916 | $ | 5,119 | |
Europe | 43 | 113 | |||
Consolidated Total | $ | 1,959 | $ | 5,232 | |
DEBT
DEBT | 12 Months Ended |
31-May-14 | |
DEBT | ' |
DEBT | ' |
F. DEBT | |
PRIDES CROSSING CAPITAL | |
On May 10, 2013, the Company entered into a loan agreement (the “Loan Agreement”) with Prides Crossing Capital, L.P. and Prides Crossing Capital-A, L.P., (“Lenders”). The Loan Agreement provided for a $2.7 million, three-year term loan (the “Loan”) with interest only payments until October 1, 2014. | |
On July 9, 2013, the Loan Agreement was amended (the “Amended Loan Agreement No. 1”) to allow the Company to repurchase 170,000 of its shares from Greenleaf (as described in Note J) and to increase the maximum ratio of indebtedness to EBITDA from 2.25:1 to 2.60:1 for the quarters ended May 31, 2013, August 31, 2013 and November 30, 2013. In consideration for entering into the Amended Loan Agreement No. 1, the Company issued the Lenders warrants to purchase 25,000 shares of common stock at an exercise price of $1.00 per share. The warrants were to vest monthly over three years, with accelerated vesting under certain circumstances including if the Loan was repaid prior to maturity, and terminate if not exercised on or before July 9, 2020. | |
Upon issuance, the warrants did not meet the requirements for equity classification, because such warrants provide a cash-out election allowing the holder to a one time right to require the Company to repurchase all or a portion of the warrants. Therefore these warrants were required to be accounted for as a liability. Changes in fair value are recognized as either a gain or loss in the consolidated statement of operations under the caption “Other income, net.” | |
The Company determined the fair value of the warrants using the Black-Scholes valuation model. The grant date fair value of the warrants of approximately $51,000 was recorded as a liability, with a corresponding discount recorded on the debt. The debt discount is being accreted through the remaining term of the Loan Agreement using the effective interest rate method. | |
On December 5, 2013, the Company entered into the Amended Loan Agreement No. 2 between the Company, as borrower and Prides Crossing Capital Funding, L.P., as the Lender whereby the parties agreed to amend and restate the Company’s existing $2.7 million Loan Agreement following the CADRA Sale. The Lender was the successor to Prides Crossing Capital, L.P. and Prides Crossing Capital-A, L.P., the Lenders under the Loan Agreement. Under the terms of the Amended Loan Agreement No. 2, the Company agreed to pay down the principal of the Loan from $2.7 million to $1.0 million using a portion of the proceeds from the CADRA Sale. In addition, the Company paid a pre-payment penalty of $81,000 and agreed to repurchase the outstanding warrants to purchase 25,000 shares of common stock at an exercise price of $1.00 per share in exchange for $19,000. | |
The amended and restated Term Note matures on January 1, 2015 and bears an interest rate of 14% payable in arrears on a monthly basis throughout the life of the loan commencing on January 1, 2014. The Term Note may be repaid in full at any time but partial voluntary pre-payments are not allowed. If a pre-payment is made on or prior to September 30, 2014, the Company shall pay a yield maintenance fee equal to the interest that would have accrued under the Term Note from the date of pre-payment through September 30, 2014. No yield maintenance fee is due for a pre-payment made subsequent to September 30, 2014. | |
The Company agreed to secure all of its obligations under the Term Note by granting the Lender a first priority security interest in all of the Company’s assets, including the Company’s intellectual property and pledges of (i) one hundred percent (100%) of the Company’s equity interests in its domestic subsidiaries and (ii) sixty-five percent (65%) of the Company’s equity interests in its foreign subsidiaries. In connection with the grant of the security interest in favor of the Lender in the Company’s intellectual property, the Company has entered into an intellectual property security agreement with the Lender and entered into a source code escrow agreement with the Lender and an independent third party. In addition, the Company’s Chief Executive Officer has provided the Lender with a personal guaranty of up to $500,000 secured by his equity interests in the Company. | |
The Term Note contains customary representations, warranties and covenants, including covenants by the Company limiting additional indebtedness, liens, guaranties, mergers and consolidations, substantial asset sales, investments and loans, sale and leasebacks, transactions with affiliates and fundamental changes in its business. In addition, the Term Note contains financial covenants by the Company that establish (i) a month-end minimum consolidated cash balance of $1.0 million of which no less than $750,000 must be held in the Company’s main operating account that is subject to a deposit account control agreement; (ii) a minimum of $750,000 of consolidated cash at all times; (iii) a quick ratio covenant, which provides that on the last day of each fiscal quarter the ratio of the Company’s cash plus accounts receivable divided by accounts payable plus accrued expenses shall not be less than 2.7:1; and (iv) a covenant that provides that the Company’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for Q3 and Q4 of fiscal 2014 shall not exceed a loss of $200,000 for each of those fiscal quarters and shall be greater than positive EBITDA of $100,000 for each subsequent fiscal quarter. The Term Note also imposes limits on capital expenditures for each fiscal year during the term of the Term Note. The Company, the Lender and First Republic Bank entered into a deposit account control agreement pursuant to which the Lender will perfect its security interest in the assets held in the Company’s main operating account at First Republic Bank. | |
The Term Note provides for events of default customary for credit facilities of this type, including but not limited to non-payment, defaults on other debt, misrepresentation, breach of covenants, representations and warranties, insolvency and bankruptcy. Upon an event of default relating to insolvency, bankruptcy or receivership, the amounts outstanding under the Term Note will become immediately due and payable and the Lender commitment will be automatically terminated. Upon the occurrence and continuation of any other event of default, the Lender may accelerate payment of all obligations and terminate the Lender’s commitments under the Term Note |
LEASE_COMMITMENTS
LEASE COMMITMENTS | 12 Months Ended | ||
31-May-14 | |||
LEASE COMMITMENTS | ' | ||
LEASE COMMITMENTS | ' | ||
G. LEASE COMMITMENTS | |||
OPERATING LEASES | |||
The Company conducts its operations in office facilities leased through December 2018. Rental expense for fiscal years 2014 and 2013 was approximately $181,000 and $194,000, respectively. The Company has the option to terminate the lease in March 2017 by paying a termination fee of approximately $77,000. | |||
At May 31, 2014, minimum annual rental commitments under noncancellable leases were as follows (in thousands): | |||
Fiscal Year ending May 31: | |||
2015 | $ | 133 | |
2016 | 133 | ||
2017 | 110 | ||
Total future minimum lease commitments | 376 | ||
CAPITAL LEASES | |||
In fiscal years 2010, 2013 and 2014, the Company acquired capital equipment through a capital lease agreements with financial institutions for a terms of 50 and 60 months, with a $1 purchase option. The assets are amortized over the life of the related lease and amortization of the assets is included in depreciation expense for fiscal year 2014 and 2013. Minimum annual future lease payments under the capital lease as of May 31, 2014 are as follows (in thousands): | |||
2015 | $ | 23 | |
2016 | 23 | ||
2017 | 23 | ||
2018 | 13 | ||
2019 | 5 | ||
Minimum lease payment | 87 | ||
Amount representing interest | -21 | ||
Present value of minimum lease payments | $ | 66 | |
Current | $ | 19 | |
Long Term | $ | 47 | |
Note_Receivable
Note Receivable | 12 Months Ended |
31-May-14 | |
Receivables, Loans, Notes Receivable, and Others: | ' |
Note Receivable | ' |
H. NOTE RECEIVABLE | |
Joseph Mullaney, the Company’s CEO, was extended a non-interest bearing note in the amount of $134,000 related to a stock transaction in May 1998. The note is partially secured by the Company stock acquired in that transaction. The Company has accounted for the note as a fixed arrangement. | |
RIGHTS_AGREEMENT
RIGHTS AGREEMENT | 12 Months Ended |
31-May-14 | |
Rights Agreement: | ' |
RIGHTS AGREEMENT | ' |
I. RIGHTS AGREEMENT | |
On February 3, 2012, the Company entered into a Rights Agreement with Registrar and Transfer Company, as Rights Agent, dated as of February 3, 2012 (the “Rights Agreement”). By adopting the Rights Agreement, the Board of Directors was seeking to protect the Company’s ability to carry forward its net operating losses and certain other tax attributes (collectively, “NOLs”). The Company has experienced and may continue to experience substantial operating losses, and for federal and state income tax purposes, the Company may “carry forward” net operating losses in certain circumstances to offset current and future taxable income, which will reduce federal and state income tax liability, subject to certain requirements and restrictions. These NOLs are a valuable asset of the Company, which may inure to the benefit of the Company and its shareholders. However, if the Company experiences an “ownership change,” as defined in Section 382 of the Internal Revenue Code (the “Code”), its ability to use the NOLs could be substantially limited, and the timing of the usage of the NOLs could be substantially delayed, which could significantly impair the value of the Company’s NOL asset. Generally, an “ownership change” occurs if the percentage of the Company’s stock owned by one or more “five percent stockholders” increases by more than fifty percentage points over the lowest percentage of stock owned by such stockholders at any time during the prior three-year period or, if sooner, since the last “ownership change” experienced by the Company. An NOL rights agreement like the Rights Agreement with a 4.99% “trigger” threshold is intended to act as a deterrent to any person acquiring 4.99% or more of the outstanding shares of common stock without the approval of the Board of Directors. This would protect the Company’s NOL asset because changes in ownership by a person owning less than 4.99% of the common stock are not included in the calculation of “ownership change” for purposes of Section 382 of the Code. | |
In connection with the Rights Agreement, the Board of Directors of the Company declared a dividend of one common share purchase right (a “Right”) for each outstanding share of common stock, par value $0.10 per share, of the Company. The dividend was issued on February 15, 2012 to the stockholders of record on February 15, 2012. Each Right entitles the registered holder to purchase from the Company one share of common stock in certain circumstances at a price of $5.00 per share of common stock, subject to adjustment. | |
In the event that a person or group of affiliated or associated persons becomes an Acquiring Person, as defined in the Rights Agreement, each holder of a Right, other than Rights beneficially owned by the Acquiring Person (which will thereupon become void), will thereafter have the right to receive upon exercise of a Right that number of shares of common stock having a market value of two times the purchase price of the Right. |
Stock_Purchase_Agreement
Stock Purchase Agreement | 12 Months Ended |
31-May-14 | |
Stock Purchase Agreement | ' |
Stock Purchase Agreement Text Block | ' |
J. STOCK PURCHASE AGREEMENT | |
In June 2013, the Company purchased 170,000 shares of common stock from Greenleaf, The Ronda E. Stryker and William D. Johnston Foundation, and The L. Lee Stryker 1974 Irrevocable Trust fbo Ronda E. Stryker, for a purchase price of $62,900 or $0.37 per share as detailed in Note K to the consolidated financial statements as of May 31, 2013. The agreement provides an option for the Company to either make an offer to purchase the remaining 101,411 shares held by Greenleaf at $0.37 per share or to provide Greenleaf with registration rights with respect to the remaining shares as set forth in the Registration Rights Agreement dated March 8, 2011. Greenleaf is under no obligation to accept the Company’s offer to purchase the remaining shares on the terms set forth above, however, if the offer is made by the Company and rejected, the Company will no longer be obligated to provide Greenleaf with registration rights with respect to the remaining shares. As part of the agreement, Greenleaf agreed not to sell or transfer the shares for a one year period from the transaction date. On August 8, 2014 the Company repurchased Greenleaf’s remaining 101,411 shares at $0.37 per share for a total of approximately $38,000. |
Sale_of_Patents
Sale of Patents | 12 Months Ended |
31-May-14 | |
Sale of Patents | ' |
Sale of Patents | ' |
K. SALE OF PATENTS | |
In June 2012, the Company sold to an unrelated third party (the “Buyer”) its rights, title and interests in three of its U.S. patents (the “Patents”) all entitled Method and System for Design and Drafting in exchange for a non-refundable, initial royalty payment of $200,000 (the “Initial Payment”). These Patents were derived from the Company’s development work related to the Company’s CADRA product line and the inventions are a key, time saving feature within that technology offering. The Company received a limited, non-exclusive, royalty-free license under the Patents to make, use, offer to sell, or sell the Company’s products or services. | |
In September 2012, the agreement was amended to include two other U.S. patents (“Additional Patents”) both entitled Product Development System and Method Using Integrated Process and Data Management. These Additional Patents were derived from the development work related to the Company’s ProductCenter product line and are a core and essential capability within that product offering. The Company received a limited, non-exclusive, royalty-free license under the Additional Patents to make, use, offer to sell or sell the Company’s products or services. As a result of the amendment, the Initial Payment was increased by $100,000. | |
The agreement gives the Buyer complete control over what, if any, actions shall be taken in the future to monetize the Patents and the Additional Patents through licensing, sale, enforcement or other means. In the event whereby monies are derived from the Patents and the Additional Patents, the Company is due 30% of the net proceeds (the “Net Proceeds”), as defined in the agreement. The Initial Payment shall be reimbursable from Net Proceeds to the extent any are due. There can be no assurance that the Company will derive any additional monies from the agreement, however. | |
The sale of the Patents and Additional Patents is a multiple element arrangement as defined under ASC 605 and, as such, the Company allocated the Initial Payment between the sale of the Patents and Additional Patents that were delivered during the fiscal quarter and support services that were undelivered. Support services include being available to the Buyer to assist them should they require such assistance in licensing or pursuing other means of monetizing the Patents and Additional Patents to third parties. The allocation of the Initial Payment to the patent and support services elements was based on management’s best estimate of the selling price of each element. The Initial Payment was allocated as follows: Patents - $290,000; and Support Services - $10,000. Additional monies due the Company in the form of royalties from its 30% share of Net Proceeds will be recorded in the quarterly period in which the Buyer notifies the Company such payments are due. Such notification and payment, if any, are due thirty calendar days after the end of each calendar quarter. The revenue allocated to support services was recognized during the fiscal year ended 2014 as all services had been performed. | |
The Company retained its U.S. patent applications that it acquired or filed since the Recapitalization Transaction in March 2011. These patent applications were not included in the above described agreement. The Company expects to be actively engaged with the U.S. Patent and Trademark Office for the foreseeable future with regard to those filings. | |
CADRA_Sale
CADRA Sale | 12 Months Ended | ||
31-May-14 | |||
CADRA Sale: | ' | ||
CADRA Sale | ' | ||
L. CADRA SALE | |||
On October 18, 2013, the Company sold substantially all of the assets of its CADRA product line, including all intellectual property related to that technology but specifically excluded cash, billed accounts receivable and liabilities other than the deferred maintenance liability associated with CADRA customer maintenance contracts for support services, to Mentor, pursuant to an Asset Purchase Agreement dated August 30, 2013. The aggregate consideration for the CADRA Sale is up to $3.95 million, which is comprised of (i) $2.88 million of which was paid on the closing date; (ii) $320,000 (representing a 10% holdback) of which will be paid on the one year anniversary of the closing date (subject to any indemnification claims), and (ii) Earn-Out Payments of up to an aggregate $750,000 over the three-year period subsequent to the closing date, based on 10% of the net revenue generated by the CADRA business , subject to the terms of the Earn-Out Agreement dated August 30, 2013. | |||
The Company will continue to sell and support the CADRA technology throughout Europe (except Germany) and, for a one year period from the closing, will retain the rights to sell and support the technology to the largest U.S. CADRA user, Sikorsky Aircraft. | |||
The transaction generated a gain during fiscal year 2014 which was composed of the following (000’s): | |||
Proceeds from the sale of the CADRA technology | $ | 2,880 | |
Fair value of the Holdback Payment and the Earn-Out Payments | 922 | ||
Liabilities assumed by Mentor related to deferred maintenance obligations | 607 | ||
Professional fees and other expenses related to the transaction | -448 | ||
Goodwill allocated to the CADRA product line | -3,305 | ||
Net book value of equipment transferred in the sale | -7 | ||
Gain on sale of CADRA product line | $ | 649 |
Subsequent_Events
Subsequent Events | 12 Months Ended | ||||
31-May-14 | |||||
Subsequent Events | ' | ||||
Subsequent Events | ' | ||||
M. SUBSEQUENT EVENTS | |||||
The Company has evaluated all events and transactions that occurred after the balance sheet and through the date that the financial statements were available to be issued. | |||||
On June 20, 2014, the Company entered into three agreements: a securities purchase agreement (the “Share Purchase Agreement”) with Mr. Joseph P. Daly, an existing SofTech shareholder; a promissory note agreement (the “Note”) with EssigPR, Inc. (“EssigPR”), a Puerto Rico corporation; and a partnership agreement (the “Partnership Agreement”) with Essig Research, Inc. (“Essig”), a corporation based in Cincinnati, Ohio. EssigPR and Essig are owned by the aforementioned Mr. Daly. Each of the agreements between the parties is briefly described below. | |||||
Under the Share Purchase Agreement dated June 20, 2014, Mr. Daly, Essig’s CEO and owner, purchased 110,000 shares of SofTech common stock, par value $0.10 per share for $550,000, in a direct private placement. Mr. Daly shall have the right to require the Company to repurchase some or all of the shares at $7.00 per share during the ninety (90) day period immediately following the three-year anniversary of the purchase date. | |||||
The Note is a three (3) year borrowing arrangement with EssigPR as the lender. The promissory note is a $750,000 term loan maturing on April 1, 2017, that accrues interest at a 9.5% interest rate, paid quarterly in arrears. The principal on the Note will be paid from the deferred payments (Holdback Payment and Earn-Out Payments) due over the next three years from Mentor in connection with their purchase of the CADRA product line as described herein. The Company is responsible for ensuring that the Mentor deferred payments are sufficient for paying down the Note or, on April 1, 2017, making up for any shortfall. Mentor deferred payments in excess of amounts due under the Note revert to the Company. | |||||
On October 1, 2014, the Company entered into an additional short term borrowing arrangement with EssigPR (“Short Term Note”) whereby it was agreed that the Company would retain $300,000 of the Holdback Payment due from Mentor in October 2014 rather than utilize those monies to pay down the above described Note. The interest rate on the Short Term Note is 9.5%, payable quarterly in arrears. The Short Term Note can be repaid at any time without penalty and is due in full on April 10, 2015. EssigPR was awarded 5,000 stock options to purchase SofTech common stock at $1.00 per share. The stock options will expire on October 1, 2024 if not exercised. | |||||
The Partnership Agreement is an arrangement whereby the Company and Essig have agreed to work together to market and deliver Essig’s professional services capabilities to the SofTech customer base. In addition, the Company has agreed to provide office space for up to fifteen (15) Essig employees or contractors at no charge at its facility in Massachusetts. The Partnership Agreement expires on April 1, 2017. | |||||
In June 2014, each of the Investors in the fiscal year 2013 Redeemable Common Stock arrangement described in Note B. above exercised their Put Option. The Company repurchased those 50,000 shares in exchange for $275,000 in accordance with the terms of those Stock Purchase Agreements. | |||||
On August 8, 2014, the Company purchased 101,411 shares of its common stock from Greenleaf in exchange for $37,522, or $0.37 per share. | |||||
In three transactions in late September 2014, the Company raised proceeds of $250,000 from the issuance of an aggregate of 50,000 shares of the Company’s common stock, par value $0.10 per share, at $5.00 per share to accredited investors in separate private placement transactions. | |||||
These transactions were completed pursuant to Securities Purchase Agreements which the Company entered into with each of the investors as described in the table below. | |||||
The material terms of the Securities Purchase Agreements are summarized below. | |||||
· Number of Shares Sold: An aggregate of 50,000 shares of the Company’s common stock, par value $0.10 per share; | |||||
· Purchase Price Per Share: The shares were sold to investors at a purchase price of $5.00 per share in lots of 10,000 shares; | |||||
· Type of Offering: Direct private placement to accredited investors; no registration rights; no third party placement fees; | |||||
· Fees: In lieu of registration rights and Company costs savings related to direct negotiation with accredited investors, each $50,000 investment entitles the investor to a fee of $5,000 to be paid in eight equal quarterly installments during the twenty-four month period following the investment; and | |||||
· Purchase Put Right: Each share purchased shall also give the investors the right to require the Company to repurchase the shares at $7.00 for the 30 day period following the twenty-four month anniversary of the investment. | |||||
The Company does not believe that the issuance of such shares will restrict the Company’s ability to utilize its net operating losses. Accordingly, the Board of Directors of the Company approved in advance the purchase of the shares in these transactions as “Exempt Transactions” as defined in Section 1(o) of the Company’s Rights Agreement, dated February 3, 2012, between the Company and the Registrar and Transfer Company. | |||||
Name of Accredited Investor | Date of Securities Purchase Agreement | Amount of Investment in Transaction ($/# of Shares Purchased) | |||
Robert Anthonyson | 18-Sep-14 | $100,000 / 20,000 shares | |||
Glenn W. Dillon | 22-Sep-14 | $100,000 / 20,000 shares | |||
Thomas Doherty | 22-Sep-14 | $50,000 / 10,000 shares | |||
Mr. Anthonyson is the Vice President and is member of the Board of Directors of the Company. He owned 129,838 shares of common stock prior to the above described transaction. | |||||
The offer and sale of securities in the private placements described above were made to “accredited investors” (as defined in Rule 501(a) under the Securities Act) in reliance on the exemption from registration provided by Section 4(2) of the Securities Act of 1933 and Rule 506 thereunder. |
ACCOUNTING_POLICIES_Policies
ACCOUNTING POLICIES (Policies) | 12 Months Ended | ||||||||
31-May-14 | |||||||||
ACCOUNTING POLICIES | ' | ||||||||
USE OF ESTIMATES | ' | ||||||||
USE OF ESTIMATES | |||||||||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, the allowance for doubtful accounts receivable, the fair value estimate of the Holdback Payment and Earn-Out Payments due from Mentor related to the sale of the CADRA business and the valuation of long term assets including goodwill, capitalized patent costs, capitalized software development costs and deferred tax assets. Actual results could differ from those estimates. | |||||||||
CASH AND CASH EQUIVALENTS, Policy | ' | ||||||||
CASH AND CASH EQUIVALENTS | |||||||||
The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains cash at certain financial institutions in amounts that at times, exceed Federal Deposit Insurance Corporation limits. Cash held in foreign bank accounts at May 31, 2014 totaled approximately $182,000. The Company does not believe it is exposed to significant credit risk related to cash and cash equivalents. | |||||||||
CONCENTRATION OF CREDIT RISK, Policy | ' | ||||||||
CONCENTRATION OF CREDIT RISK | |||||||||
The Company believes that the loss of one or more of our largest customers could have a material adverse effect on the business. During fiscal years 2014 and 2013, no customer exceeded ten percent of revenue. The Company generally does not require collateral on credit sales. Management evaluates the creditworthiness of customers prior to delivery of products and services and provides allowances at levels estimated to be adequate to cover any potentially uncollectible accounts. Bad debts are written off against the allowance when identified. The changes in the accounts receivable reserve are as follows (in thousands): | |||||||||
For the Years Ended May 31, | Balance, Beginning of Period | Charged to Costs and Expenses | Bad Debt Write-offs | Balance, End of Period | |||||
2013 | $ | 29 | $ | - | $ | - | $ | 29 | |
2014 | $ | 29 | $ | 44 | $ | 55 | $ | 18 | |
PROPERTY AND EQUIPMENT, Policy | ' | ||||||||
PROPERTY AND EQUIPMENT | |||||||||
Property and equipment is stated at cost. The Company provides for depreciation on a straight-line basis over the following estimated useful lives: | |||||||||
Data Processing Equipment | 2-5 years | ||||||||
Office furniture | 5-10 years | ||||||||
Automobiles | 4-6 years | ||||||||
Depreciation expense, including amortization of assets under capital lease, was approximately $37,000 and $35,000, for fiscal years 2014 and 2013, respectively. | |||||||||
Maintenance and repairs are charged to expense as incurred; betterments are capitalized. At the time property and equipment are retired, sold, or otherwise disposed of, the related costs and accumulated depreciation are removed from the accounts. Any resulting gain or loss on disposal is credited or charged to income. | |||||||||
SOFTWARE DEVELOPMENT COSTS | ' | ||||||||
SOFTWARE DEVELOPMENT COSTS | |||||||||
The Company accounts for its software development costs in accordance with Accounting Standards Codification (“ASC”) 985, Costs of Computer Software to Be Sold, Leased or Marketed. Costs that are incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, software development costs are capitalized until the product is available for general release to customers. Such costs are amortized using the straight-line method over the estimated economic life of the product, generally three years. The Company evaluates the realizability of the assets and the related periods of amortization on a regular basis. Judgment is required in determining when technological feasibility of a product is established as well as its economic life. | |||||||||
During fiscal years 2014 and 2013, the Company capitalized approximately $57,000 and $276,000, respectively, of software development costs. Amortization expense related to capitalized software development costs for fiscal years 2014 and 2013 was approximately $114,000 and $73,000, respectively. | |||||||||
DEBT ISSUANCE COSTS POLICY | ' | ||||||||
DEBT ISSUANCE COSTS | |||||||||
The Company capitalizes the direct costs associated with entering into debt agreements and amortizes those costs over the life of the debt agreement. In May 2013, the Company entered into the Loan Agreement as detailed in Note F. Total direct costs incurred in establishing this debt agreement were approximately $255,000 which are being amortized over the term of the arrangement in accordance with ASC 470-50. During the fiscal year ending 2014, the Company capitalized approximately $31,000 of debt issuance costs related to the Loan Agreement. Unamortized debt issuance costs related to the prior credit facility totaled approximately $108,000 and were expensed in Q4 of fiscal 2013. Amortization expense related to debt issuance costs for fiscal years 2014 and 2013 was approximately $143,000 and $225,000, respectively. | |||||||||
Amended Loan Agreement No. 2 described in Note F hereunder was a modification per ASC 470-50, Debt Modifications and Extinguishment, therefore the direct costs totaling approximately $120,000 incurred in completing the modification were expensed. | |||||||||
INCOME TAXES Policy | ' | ||||||||
INCOME TAXES | |||||||||
The provision for income taxes is based on the earnings or losses reported in the consolidated financial statements. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The Company provides a valuation allowance against deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. | |||||||||
The Company recognizes the tax benefit from an uncertain tax position only if it more-likely-than-not that the tax position will be sustained upon examination by taxing authorities, based on technical merits of the tax position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, changes in the tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, and changes in facts or circumstances related to a tax position. Any changes to these estimates, based on the actual results obtained and/or a change in assumptions, could impact the Company’s tax provision in future periods. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for federal and state income taxes. In accordance with the applicable statute of limitations, the Company’s tax returns could be audited by the Internal Revenue Service and various states for the fiscal years ended 2011 to 2013. | |||||||||
REVENUE RECOGNITION | ' | ||||||||
REVENUE RECOGNITION | |||||||||
The Company follows the provisions of ASC 985, Software, for transactions involving the licensing of software and software support services. Revenue from software license sales is recognized when persuasive evidence of an arrangement exists, delivery of the product has been made, and a fixed fee and collectability has been determined. The Company does not provide for a right of return. For multiple element arrangements, total fees are allocated to each of the undelivered elements based upon vendor specific objective evidence (“VSOE”) of their fair values, with the residual amount recognized as revenue for the delivered elements, using the residual method set forth in ASC 985. Revenue from customer maintenance support agreements is deferred and recognized ratably over the term of the agreements, typically one year. Revenue from engineering, consulting and training services is recognized as those services are rendered using a proportional performance model. | |||||||||
The Company follows the provisions of ASC 605, Revenue Recognition for transactions that do not involve the licensing of software or software support services as in the case of the recent sale of its patents. Revenue from the sale of patents is recorded when persuasive evidence of an arrangement exists, delivery has taken place and a fixed fee and collectability has been determined. These conditions are no different from those when the Company licenses software. For multiple element arrangements, however, under ASC 605, total fees are allocated to each of the elements based upon the relative selling price method. Under that method the allocation of fees to the undelivered elements is based on VSOE, or if it doesn’t exist, then based on third party evidence of selling price. If neither exists, then the allocation is based on management’s best estimate of the selling price. | |||||||||
PATENT COSTS, POLICY | ' | ||||||||
PATENT COSTS | |||||||||
Costs related to patent applications are capitalized as incurred and are amortized once the patent application is accepted or are expensed if the application is finally rejected. Patent costs are amortized over their estimated economic lives under the straight-line method, and are evaluated for impairment when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable through the estimated undiscounted future cash flows from the use of the associated patent. Capitalized patent costs totaled approximately $6,000 and $19,000 for the years ending May 31, 2014 and 2013, respectively. | |||||||||
ACCOUNTING FOR GOODWILL | ' | ||||||||
ACCOUNTING FOR GOODWILL | |||||||||
The Company accounts for goodwill pursuant to ASC 350, Intangibles – Goodwill and Other. This requires that goodwill be reviewed annually, or more frequently as a result of an event or change in circumstances, for possible impairment with impaired assets written down to fair value. Additionally, existing goodwill and intangible assets must be assessed and classified within the statement’s criteria. | |||||||||
During fiscal year 2014, the Company completed the CADRA Sale as described above. The Company attributed a portion of its total goodwill to the CADRA product line and expensed it in the derivation of the gain on the sale. The portion of the total goodwill apportioned to the CADRA product line was equal to the estimated market value of the CADRA product line as compared to the total market value of the Company. | |||||||||
As of May 31, 2014, the Company conducted its annual impairment test of goodwill by comparing the fair value of the reporting unit to the carrying amount of the underlying assets and liabilities of its single reporting unit. The Company determined that the fair value of the reporting unit exceeded the carrying amount of the assets and liabilities, therefore no impairment existed as of the testing date. | |||||||||
LONG-LIVED ASSETS | ' | ||||||||
LONG-LIVED ASSETS | |||||||||
The Company periodically reviews the carrying value of all intangible and other long-lived assets. If indicators of impairment exist, the Company compares the undiscounted cash flows estimated to be generated by those assets over their estimated economic life to the related carrying value of those assets to determine if the assets are impaired. If the carrying value of the asset is greater than the estimated undiscounted cash flows, the carrying value of the assets would be decreased to their fair value through a charge to operations. As of May 31, 2014, the Company does not have any long-lived assets it considers to be impaired. | |||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | ' | ||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS | |||||||||
Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company is required to classify certain assets based on the fair value hierarchy, which groups fair value-measured assets based upon the following levels of inputs: | |||||||||
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; | |||||||||
Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; | |||||||||
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). | |||||||||
The assets maintained by the Company that are required to be measured at fair value on a recurring basis include the Holdback Payment and Earn-Out Payments associated with the Company’s sale of the CADRA product line. | |||||||||
The following table summarizes the valuation of the Company's assets and liabilities measured at fair value on a recurring basis as of May 31, 2014: | |||||||||
(in thousands) | |||||||||
Total | Quoted prices in active markets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | ||||||
Assets: | |||||||||
Holdback Payment and Earn-Out Payments | $ | 895 | $ | - | $ | - | $ | 895 | |
Total assets at fair value | $ | 895 | $ | - | $ | - | $ | 895 | |
The Holdback Payment and Earn-Out Payments are classified as current or non-current assets depending on their anticipated distributions to the Company. | |||||||||
The table below provides a summary of the changes in fair value of the Level 3 classified Holdback Payment and Earn-Out Payments asset for the year ended May 31, 2014: | |||||||||
(in thousands) | |||||||||
Contingent Consideration for the Year Ended May 31, 2014 | |||||||||
Fair value at inception | $ | 922 | |||||||
Payments received | -44 | ||||||||
Change in fair value | 17 | ||||||||
Fair value at end of period | $ | 895 | |||||||
The fair value of the asset at May 31, 2014 was approximately $895,000. The fair value of the Holdback Payment and the Earn-Out Payments expected to be collected in fiscal 2015 have been classified as current assets. The fair value of the payments expected to be received beyond fiscal 2015 are included in long term assets in the accompanying consolidated balance sheet. The Company has estimated the fair value of the Holdback Payment and Earn-Out Payments using a discounted cash flow approach. This valuation is based upon several factors including; i) management’s estimate of the amount and timing of future CADRA revenues, ii) the timing of receipt of payments from Mentor, and iii) a discount rate of 7%. | |||||||||
A change in any of these unobservable inputs can significantly change the fair value of the asset. The change in fair value of the asset recognized in the Consolidated Statements of Operations for the year ended May 31, 2014 was approximately $17,000. | |||||||||
FOREIGN CURRENCY TRANSLATION | ' | ||||||||
FOREIGN CURRENCY TRANSLATION | |||||||||
The functional currency of the Company’s foreign operations (Germany, and Italy) is the Euro. As a result, assets and liabilities are translated at period-end exchange rates and revenues and expenses are translated at the average exchange rates. Adjustments resulting from translation of such financial statements are classified in accumulated other comprehensive income (loss). Foreign currency gains and losses arising from transactions were included in operations in fiscal year 2014 and 2013. In fiscal year 2014 and 2013, the Company recorded a net gain from foreign currency related transactions of approximately $(33,000) and $(7,000), respectively, to Other income, net in the Consolidated Statements of Operations. | |||||||||
COMPREHENSIVE INCOME (LOSS), Policy | ' | ||||||||
COMPREHENSIVE INCOME (LOSS) | |||||||||
Comprehensive income (loss) is a more inclusive reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income (loss). To date, the Company’s comprehensive income items include only foreign translation adjustments. Comprehensive income (loss) has been included in the Consolidated Statements of Comprehensive Income (Loss) for all periods. | |||||||||
NET INCOME (LOSS) PER COMMON SHARE POLICY | ' | ||||||||
NET INCOME (LOSS) PER COMMON SHARE | |||||||||
Basic net income (loss) per share are computed by dividing the net income (loss) by the weighted-average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted-average number of common and equivalent dilutive common shares outstanding. For periods in which losses are reported potentially dilutive common stock equivalents are excluded from the calculation of diluted loss per share because the effect is anti-dilutive. | |||||||||
The following table details the derivation of weighted average shares outstanding used in the calculation of basic and diluted net income (loss) for each period: | |||||||||
(Amounts in thousands, except share amounts) | |||||||||
Years Ended | |||||||||
May 31, | May 31, | ||||||||
2014 | 2013 | ||||||||
Net income (loss) available to common shareholders | $ | -748 | $ | 360 | |||||
Weighted average number of common shares outstanding used in calculating basic earnings per share | 876,860 | 1,018,709 | |||||||
Weighted average number of common shares outstanding used in calculating diluted earnings per share | 876,860 | 1,019,812 | |||||||
For the fiscal year ending May 31, 2014, 129,500 options to purchase common shares were anti-dilutive and were excluded from the above calculation. | |||||||||
STOCK-BASED COMPENSATION POLICY | ' | ||||||||
STOCK-BASED COMPENSATION | |||||||||
Stock-based compensation expense for all stock-based payment awards made to employees and directors is measured based on the grant-date fair value of the award. The Company estimated the fair value of each share-based award using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions as to stock price volatility, the expected life of options, a risk-free interest rate and dividend yield. The Company recognizes stock-based compensation expense on a straight-line basis over the requisite service period of the award. | |||||||||
In May 2011, the 2011 Equity Incentive Plan (the “2011 Plan”) was approved by the Company’s shareholders, pursuant to which 150,000 shares of our common shares are reserved for issuance. Any shares subject to any award under the 2011 Plan that expires, is terminated unexercised or is forfeited will be available for awards under the 2011 Plan. The Company may grant stock options, restricted stock, restricted stock units, stock equivalents and awards of shares of common stock that are not subject to restrictions or forfeiture under the 2011 Plan. As of May 31, 2014, 129,500 options were awarded. | |||||||||
The following table summarizes option activity under the 1994 and the 2011 Stock Option Plan: | |||||||||
Number of Options | Weighted Average Exercise Price Per Share | Weighted-Average Remaining Life (in years) | Aggregate Intrinsic Value | ||||||
Outstanding options at May 31, 2012 | 10,000 | 2.4 | 9.02 | - | |||||
Granted | - | - | - | - | |||||
Exercised | - | - | - | - | |||||
Forfeited or expired | - | - | - | - | |||||
Outstanding options at May 31, 2013 | 10,000 | 2.4 | 8.02 | - | |||||
Granted | 124,500 | 1.84 | 10 | - | |||||
Exercised | - | - | - | - | |||||
Forfeited or expired | -5,000 | 1.11 | - | - | |||||
Outstanding options at May 31, 2014 | 129,500 | $ | 1.88 | 9.74 | $ | 20,825 | |||
Exercisable at May 31, 2014 | 10,493 | $ | 2.17 | 8.49 | $ | 868 | |||
The Company determined the volatility for options granted during the fiscal year ended May 31, 2014 and 2013 using the historical volatility of the Company’s common stock. The expected life of options has been determined utilizing the “simplified” method as prescribed in ASC 718 Compensation, Stock Compensation. The expected life represents an estimate of the time options are expected to remain outstanding. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. The Company has not paid, and does not anticipate paying, cash dividends on its common stock; therefore, the expected dividend yield is assumed to be zero. | |||||||||
For the years ended May 31, 2014 and 2013, the Company expensed approximately $15,000 and $8,000, respectively, of stock-based compensation. The Company had approximately $207,000 of unrecorded stock-based compensation as of May 31, 2014 which will be recognized as expense over the next 2.6 years. | |||||||||
The weighted-average fair value of each option granted in the fiscal year ended May 31, 2014 is estimated as $1.73 on the date of grant using the Black-Scholes model with the following weighted average assumptions: | |||||||||
Expected life | 5.52-5.77 years | ||||||||
Assumed annual dividend growth rate | 0% | ||||||||
Expected volatility | 155% | ||||||||
Risk free interest rate | 1.46-1.96% | ||||||||
The weighted-average fair value of each option granted in the fiscal year ended May 31, 2013 is estimated as $3.32 on the date of grant using the Black-Scholes model with the following weighted average assumptions: | |||||||||
Expected life | 5.77 years | ||||||||
Assumed annual dividend growth rate | 0% | ||||||||
Expected volatility | 188% | ||||||||
Risk free interest rate | 0.95% | ||||||||
REEDEMABLE COMMON STOCK | ' | ||||||||
REDEEMABLE COMMON STOCK | |||||||||
During the year ending May 31, 2013, the Company issued 50,000 shares of common stock, $0.10 par value (the “Common Stock”) at a purchase price of $5.00 per share to accredited investors (collectively, the “Investors”) in separate private placement transactions for total proceeds of $250,000. These transactions were completed pursuant to a Securities Purchase Agreement (the “Agreement”) which the Company entered into with each of the respective Investors. In lieu of registration rights, each $25,000 investment entitled the Investors to a fee of $6,000 (the “Fee”) to be paid in six equal quarterly installments during the eighteen month period (the “Payment Period”) following the investment. The Agreement also provided the Investors with the right to require the Company to redeem the Common Stock held by such Investors (the “Put Option”) for $5.50 per share in cash for a 30 day period following the Payment Period. | |||||||||
The Company first assessed the redeemable Common Stock to determine if the instrument should be accounted for as a liability in accordance with ASC 480, Distinguishing Liabilities from Equity. In that the Put Option is optionally redeemable by the holder, the Common Stock was not required to be accounted for as a liability. Next, the Company assessed the Put Option within the redeemable Common Stock as a potential embedded derivative pursuant to the provisions of ASC 815, Derivatives and Hedging, and concluded that the Put Option did not meet the net settlement criteria within the definition of a derivative. Therefore, the Company has accounted for the Common Stock issued pursuant to the Agreement in accordance with ASC 480-10-S99-3A, Classification and Measurement of Redeemable Securities, which provides that securities that are optionally redeemable by the holder for cash or other assets are classified outside of permanent equity in temporary equity. The 50,000 shares of Common Stock issued pursuant to the Agreement were recorded as redeemable common stock at an initial carrying value of $163,000. This amount is equal to the gross proceeds of $250,000, less $27,000 in issuance costs related to legal fees and the $60,000 related to the total Fee due to each of the Investors, which has been included in other liabilities. The Company elected to record the Common Stock at its redemption value of $275,000 immediately and accordingly recorded accretion of $112,000 to additional paid in capital during fiscal year 2013. | |||||||||
Subsequent to fiscal year end, each of the Investors exercised their Put Option and the Shares were repurchased by the Company at the agreed upon Put Option price of $5.50 per share for a total of $275,000. | |||||||||
RECENT ACCOUNTING PRONOUNCEMENTS, Policy | ' | ||||||||
RECENT ACCOUNTING PRONOUNCEMENTS | |||||||||
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, (Topic 606). The ASU is the result of a joint project by the FASB and the International Accounting Standards Board (“IASB”) to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that would: remove inconsistencies and weaknesses, provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices across entities, jurisdictions, industries, and capital markets, improve disclosure requirements and resulting financial statements, and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2016. Early application is not permitted. The Company is currently assessing the impact of this guidance. |
CONCENTRATION_OF_CREDIT_RISK_T
CONCENTRATION OF CREDIT RISK (Tables) | 12 Months Ended | ||||||||
31-May-14 | |||||||||
CONCENTRATION OF CREDIT RISK (Tables): | ' | ||||||||
Bad debts are written off (Tables) | ' | ||||||||
Bad debts are written off against the allowance when identified. The changes in the accounts receivable reserve are as follows (in thousands): | |||||||||
For the Years Ended May 31, | Balance, Beginning of Period | Charged to Costs and Expenses | Bad Debt Write-offs | Balance, End of Period | |||||
2013 | $ | 29 | $ | - | $ | - | $ | 29 | |
2014 | $ | 29 | $ | 44 | $ | 55 | $ | 18 |
PROPERTY_AND_EQUIPMENT_Tables
PROPERTY AND EQUIPMENT (Tables) | 12 Months Ended | ||
31-May-14 | |||
PROPERTY AND EQUIPMENT: | ' | ||
PROPERTY AND EQUIPMENT | ' | ||
Property and equipment is stated at cost. The Company provides for depreciation on a straight-line basis over the following estimated useful lives: | |||
Data Processing Equipment | 2-5 years | ||
Office furniture | 5-10 years | ||
Automobiles | 4-6 years | ||
FAIR_VALUE_OF_FINANCIAL_INSTRU
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) | 12 Months Ended | ||||||||
31-May-14 | |||||||||
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables): | ' | ||||||||
Assets and Liabilities measured at fair value (Tables) | ' | ||||||||
The following table summarizes the valuation of the Company's assets and liabilities measured at fair value on a recurring basis as of May 31, 2014: | |||||||||
(in thousands) | |||||||||
Total | Quoted prices in active markets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | ||||||
Assets: | |||||||||
Holdback Payment and Earn-Out Payments | $ | 895 | $ | - | $ | - | $ | 895 | |
Total assets at fair value | $ | 895 | $ | - | $ | - | $ | 895 | |
Summary of the changes in fair value of the Holdback Payment and Earn-Out Payments (Tables) | ' | ||||||||
The table below provides a summary of the changes in fair value of the Level 3 classified Holdback Payment and Earn-Out Payments asset for the year ended May 31, 2014: | |||||||||
(in thousands) | |||||||||
Contingent Consideration for the Year Ended May 31, 2014 | |||||||||
Fair value at inception | $ | 922 | |||||||
Payments received | -44 | ||||||||
Change in fair value | 17 | ||||||||
Fair value at end of period | $ | 895 | |||||||
Summarizes_option_activity_Tab
Summarizes option activity (Tables) | 12 Months Ended | ||||||||
31-May-14 | |||||||||
Summarizes option activity | ' | ||||||||
Summarizes option activity | ' | ||||||||
The following table summarizes option activity under the 1994 and the 2011 Stock Option Plan: | |||||||||
Number of Options | Weighted Average Exercise Price Per Share | Weighted-Average Remaining Life (in years) | Aggregate Intrinsic Value | ||||||
Outstanding options at May 31, 2012 | 10,000 | 2.4 | 9.02 | - | |||||
Granted | - | - | - | - | |||||
Exercised | - | - | - | - | |||||
Forfeited or expired | - | - | - | - | |||||
Outstanding options at May 31, 2013 | 10,000 | 2.4 | 8.02 | - | |||||
Granted | 124,500 | 1.84 | 10 | - | |||||
Exercised | - | - | - | - | |||||
Forfeited or expired | -5,000 | 1.11 | - | - | |||||
Outstanding options at May 31, 2014 | 129,500 | $ | 1.88 | 9.74 | $ | 20,825 | |||
Exercisable at May 31, 2014 | 10,493 | $ | 2.17 | 8.49 | $ | 868 | |||
Weighted-average fair value of each option granted | ' | ||||||||
The weighted-average fair value of each option granted in the fiscal year ended May 31, 2014 is estimated as $1.73 on the date of grant using the Black-Scholes model with the following weighted average assumptions: | |||||||||
Expected life | 5.52-5.77 years | ||||||||
Assumed annual dividend growth rate | 0% | ||||||||
Expected volatility | 155% | ||||||||
Risk free interest rate | 1.46-1.96% | ||||||||
The weighted-average fair value of each option granted in the fiscal year ended May 31, 2013 is estimated as $3.32 on the date of grant using the Black-Scholes model with the following weighted average assumptions: | |||||||||
Expected life | 5.77 years | ||||||||
Assumed annual dividend growth rate | 0% | ||||||||
Expected volatility | 188% | ||||||||
Risk free interest rate | 0.95% | ||||||||
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | ||||
31-May-14 | |||||
Income Taxes (Tables): | ' | ||||
Provision for income taxes (Tables) | ' | ||||
The provision for income taxes includes the following for the years ended May 31 (in thousands): | |||||
2014 | 2013 | ||||
Federal | $ | - | $ | - | |
Foreign | - | 13 | |||
State and local | 2 | 2 | |||
Total current provision | 2 | 15 | |||
Deferred provision | 268 | 148 | |||
Valuation allowance | -268 | -148 | |||
Total deferred provision | - | - | |||
Total provision | $ | 2 | $ | 15 | |
The domestic and foreign components of income (loss) before income taxes (TABLES) | ' | ||||
The domestic and foreign components of income (loss) before income taxes were as follows for the years ended May 31 (in thousands): | |||||
2014 | 2013 | ||||
Domestic | $ | -562 | $ | 343 | |
Foreign | -184 | 32 | |||
$ | -746 | $ | 375 | ||
Federal and state statutory income tax rate (Tables) | ' | ||||
The Company’s effective income tax rates can be reconciled to the federal and state statutory income tax rate for the years ended May 31 as follows: | |||||
2014 | 2013 | ||||
Federal statutory rate | 34% | 34% | |||
State | - | - | |||
Foreign | - | 1 | |||
Permanent items | - | - | |||
Valuation reserve | -34 | -34 | |||
Effective tax rate | - | 1% | |||
Deferred tax assets (liabilities) (Tables) | ' | ||||
Deferred tax assets (liabilities) were comprised of the following at May 31 (in thousands): | |||||
2014 | 2013 | ||||
Deferred tax assets | |||||
Net operating loss carryforwards | $ | 7,271 | $ | 7,190 | |
Tax credit carryforwards | 254 | 254 | |||
Receivables allowances | 7 | 11 | |||
Vacation pay accrual | 9 | 10 | |||
Other accruals | - | - | |||
Depreciation | 37 | 35 | |||
Differences in book and tax basis of assets of acquired businesses | -859 | -1,050 | |||
Total gross deferred tax assets | 6,719 | 6,450 | |||
Valuation allowance | -6,719 | -6,450 | |||
Net deferred tax asset | $ | - | $ | - | |
Segment_Reporting_Information_
Segment Reporting Information (Tables) | 12 Months Ended | ||||
31-May-14 | |||||
Segment Reporting Information | ' | ||||
Segment Reporting Information | ' | ||||
Components of revenue and long-lived assets (consisting primarily of intangible assets, capitalized software and property, plant and equipment) by geographic location, are as follows (in thousands): | |||||
Years Ended | |||||
Revenue: | 31-May-14 | 31-May-13 | |||
North America | $ | 3,593 | $ | 4,596 | |
Asia | 493 | 603 | |||
Europe | 1,557 | 1,771 | |||
Eliminations | -634 | -612 | |||
Consolidated Total | $ | 5,009 | $ | 6,358 | |
Long-Lived Assets: | As of May 31, 2014 | As of May 31, 2013 | |||
North America | $ | 1,916 | $ | 5,119 | |
Europe | 43 | 113 | |||
Consolidated Total | $ | 1,959 | $ | 5,232 |
LEASE_COMMITMENTS_Tables
LEASE COMMITMENTS (Tables) | 12 Months Ended | ||
31-May-14 | |||
LEASE COMMITMENTS (Tables): | ' | ||
OPERATING LEASES (Tables) | ' | ||
At May 31, 2014, minimum annual rental commitments under noncancellable leases were as follows (in thousands): | |||
Fiscal Year ending May 31: | |||
2015 | $ | 133 | |
2016 | 133 | ||
2017 | 110 | ||
Total future minimum lease commitments | 376 | ||
CAPITAL LEASES (Tables) | ' | ||
Minimum annual future lease payments under the capital lease as of May 31, 2014 are as follows (in thousands): | |||
2015 | $ | 23 | |
2016 | 23 | ||
2017 | 23 | ||
2018 | 13 | ||
2019 | 5 | ||
Minimum lease payment | 87 | ||
Amount representing interest | -21 | ||
Present value of minimum lease payments | $ | 66 | |
Current | $ | 19 | |
Long Term | $ | 47 |
Transaction_Generated_a_Gain_D
Transaction Generated a Gain During Current Quarter (Tables) | 12 Months Ended | ||
31-May-14 | |||
Transaction Generated a Gain During Current Quarter | ' | ||
Transaction Generated a Gain During Current Quarter | ' | ||
The transaction generated a gain during fiscal year 2014 which was composed of the following (000’s): | |||
Proceeds from the sale of the CADRA technology | $ | 2,880 | |
Fair value of the Holdback Payment and the Earn-Out Payments | 922 | ||
Liabilities assumed by Mentor related to deferred maintenance obligations | 607 | ||
Professional fees and other expenses related to the transaction | -448 | ||
Goodwill allocated to the CADRA product line | -3,305 | ||
Net book value of equipment transferred in the sale | -7 | ||
Gain on sale of CADRA product line | $ | 649 | |
Derivation_of_weighted_average
Derivation of weighted average shares (Tables) | 12 Months Ended | ||||
31-May-14 | |||||
Derivation of weighted average shares (Tables): | ' | ||||
Derivation of weighted average shares (Tables) | ' | ||||
The following table details the derivation of weighted average shares outstanding used in the calculation of basic and diluted net income (loss) for each period: | |||||
(Amounts in thousands, except share amounts) | |||||
Years Ended | |||||
May 31, | May 31, | ||||
2014 | 2013 | ||||
Net income (loss) available to common shareholders | $ | -748 | $ | 360 | |
Weighted average number of common shares outstanding used in calculating basic earnings per share | 876,860 | 1,018,709 | |||
Weighted average number of common shares outstanding used in calculating diluted earnings per share | 876,860 | 1,019,812 | |||
Asset_Purchase_Agreement_and_o
Asset Purchase Agreement and other transactions (Details) (USD $) | Dec. 05, 2013 | Aug. 30, 2013 |
Asset purchase Agreement | ' | ' |
The aggregate consideration for the CADRA Sale is up to | ' | $3,950,000 |
The aggregate consideration for the CADRA sale comprised and paid on the closing date | ' | 2,880,000 |
Company's common stock, arranged for debt facilities | ' | 3,200,000 |
Negotiated for debt reduction from Greenleaf Capital, Inc. | ' | 7,600,000 |
Greenleaf accepted a payment in cash | ' | 2,700,000 |
Total indebtness | ' | 10,600,000 |
Company agreed to pay down the principal of the Loan Agreement maximum | 2,700,000 | ' |
Company agreed to pay down the principal of the Loan Agreement amount minimum | $1,000,000 | ' |
Liquidity_and_Subsequent_Finan
Liquidity and Subsequent Financing Events (Details) (USD $) | 12 Months Ended |
31-May-14 | |
Liquidity and Subsequent Financing Events | ' |
Company operated at a net loss during the fiscal year and used of cash in its operations | $516,000 |
Company entered into a three-year promissory note | 750,000 |
Company entered into a six-month term note | 300,000 |
Company issued shares of its common stock in private placements with four accredited investors | 160,000 |
Per share value of shares issued in private placements with four accredited investors | $5 |
Additional funds raised with the issue of shares | 800,000 |
Funds are expected to be used to pay down the Company's debt | $1,000,000 |
Significant_Accounting_Policie1
Significant Accounting Policies (details) (USD $) | 12 Months Ended | |
31-May-14 | 31-May-13 | |
Significant Accounting Policies details | ' | ' |
Capitalized patent costs incurred | $6,000 | $19,000 |
Allowance for uncollectible accounts | 18,000 | 29,000 |
Net (gain) loss from foreign currency related transactions | ($33,000) | ($7,000) |
DEBT_ISSUANCE_COSTS_Details
DEBT ISSUANCE COSTS (Details) (USD $) | 12 Months Ended | |
31-May-14 | 31-May-13 | |
DEBT ISSUANCE COSTS DURING THE PERIOD: | ' | ' |
Direct costs incurred in establishing debt agreement approximately | ' | $255,000 |
Unamortized debt issuance costs | 108,000 | ' |
Amortization expense related to debt issuance costs | 143,000 | 225,000 |
Capitalized debt issuance costs approximately | 31,000 | ' |
Direct costs totaling approximately incurred in completing the modification were expensed. | $120,000 | ' |
CONCENTRATION_OF_CREDIT_RISK_D
CONCENTRATION OF CREDIT RISK (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | 31-May-14 | 31-May-13 |
Accounts receivable reserve are as follows: | ' | ' |
Balance, Beginning of Period | $29 | $29 |
Charged to Costs and Expenses | 44 | ' |
Bad Debt Write-offs | 55 | ' |
Balance, End of Period | $18 | $29 |
SOFTWARE_DEVELOPMENT_COSTS_Det
SOFTWARE DEVELOPMENT COSTS (Details) (USD $) | 12 Months Ended | |
31-May-14 | 31-May-13 | |
SOFTWARE DEVELOPMENT COSTS DURING: | ' | ' |
Capitalized approximately | $57,000 | $276,000 |
Amortization expense related to capitalized software development costs | $114,000 | $73,000 |
PROPERTY_AND_EQUIPMENT_Details
PROPERTY AND EQUIPMENT (Details) | 31-May-14 |
Following estimated useful lives: | ' |
Data Processing Equipment Minimum Years | 2 |
Data Processing Equipment Maximum Years | 5 |
Office furniture Minimum Years | 5 |
Office furniture Maximum Years | 10 |
Automobiles Minimum Years | 4 |
AutomobilesMaximum Years | 6 |
NET_INCOME_PER_COMMON_SHARE_De
NET INCOME PER COMMON SHARE (Details) (USD $) | 12 Months Ended | |
31-May-14 | 31-May-13 | |
Calculation of basic and diluted net income: | ' | ' |
Net income available to common shareholders | ($748,000) | $360,000 |
Weighted average number of common shares outstanding used in calculating basic earnings per share | 876,860 | 1,018,709 |
Weighted average number of common shares outstanding used in calculating diluted earnings per share | 876,860 | 1,019,812 |
REEDEMABLE_COMMON_STOCK_Detail
REEDEMABLE COMMON STOCK (Details) (USD $) | 31-May-14 |
Reedemable common stock | ' |
Company issued common stock shares | 50,000 |
Par value of the share | $0.10 |
Purchase price of the share | $5 |
Private placement transactions for total proceeds | $250,000 |
company investment | 25,000 |
Investors fee | 6,000 |
Redemption price of the Common Stock per share (Put option) | $5.50 |
Redeemable common Stock initial carrying value | 163,000 |
Amount equal to gross proceeds | 250,000 |
Issuance cost related legal fee | 27,000 |
Fee included in other liabilities | 60,000 |
Common Stock recorded at its redemption value | 275,000 |
Recorded accretion to additional paid in capital | $112,000 |
Summarizes_option_activity_und
Summarizes option activity under the 2011 Plan (Details) | Number of Options | Weighted Average Exercise Price Per Share | Weighted-Average Remaining Life (in years) | Aggregate Intrinsic Value |
Outstanding options at May. 31, 2012 | 10,000 | 2.4 | 9.02 | ' |
Granted | ' | ' | ' | 0 |
Exercised | ' | ' | ' | 0 |
Forfeited or expired | ' | ' | ' | 0 |
Exercisable at May. 31, 2013 | ' | ' | ' | ' |
Outstanding options at May. 31, 2013 | ' | ' | ' | ' |
Outstanding options at May. 31, 2013 | ' | ' | ' | ' |
Outstanding options at May. 31, 2013 | 10,000 | 2.4 | 8.02 | ' |
Granted | 124,500 | 1.84 | 10 | ' |
Exercised | ' | ' | ' | 0 |
Forfeited or expired | -5,000 | 1.11 | ' | ' |
Exercisable at May. 31, 2014 | 10,493 | 2.17 | 8.49 | 868 |
Outstanding options at May. 31, 2014 | 129,500 | 1.88 | 9.74 | 20,825 |
Stock_based_compensation_Issua
Stock based compensation Issuance (details) (USD $) | 31-May-14 | 31-May-13 |
Stock based compensation Issuance | ' | ' |
weighted-average fair value of each option granted | $1.73 | $3.32 |
Options were awarded and outstanding under the 2011 Plan. | 129,500 | ' |
Expected life in years | ' | 5.77 |
Assumed annual dividend growth rate | 0.00% | 0.00% |
Expected volatility | 188.00% | 188.00% |
Risk free interest rate | ' | 0.95% |
Expected life minimum in years | 5.52 | ' |
Expected life maximum in years | 5.77 | ' |
Risk free interest rate minimum | 1.46% | ' |
Risk free interest rate maximum | 1.95% | ' |
Company expensed approximately stock-based compensation | 15,000 | 8,000 |
Unrecorded stock-based compensation | $207,000 | ' |
Unrecorded stock-based compensation recognition period in years | 2.6 | ' |
Provision_for_income_taxes_As_
Provision for income taxes As follows (details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | 31-May-14 | 31-May-13 |
Provision for income taxes As follows: | ' | ' |
Federal | $0 | $0 |
Foreign | 0 | 13 |
State and local | 2 | 2 |
Total current provision | 2 | 15 |
Deferred provision | 268 | 148 |
Valuation allowance | -268 | -148 |
Total deferred provision | 0 | 0 |
Total provision | $2 | $15 |
Domestic_and_foreign_component
Domestic and foreign components of income from income taxes (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | 31-May-14 | 31-May-13 |
Domestic and foreign components of income from income taxes: | ' | ' |
Domestic | ($562) | $343 |
Foreign, | -184 | 32 |
Total Domestic and Foreign | ($746) | $375 |
Effective_income_tax_rates_can
Effective income tax rates can be reconciled to (Details) | 12 Months Ended | |
31-May-14 | 31-May-13 | |
Effective income tax rates can be reconciled to: | ' | ' |
Federal statutory rate | 34.00% | 34.00% |
State | 0.00% | 0.00% |
Foreign. | 0.00% | 1.00% |
Permanent items | 0.00% | 0.00% |
Valuation reserve | -34.00% | -34.00% |
Effective tax rate | 0.00% | 1.00% |
Deferred_tax_assets_liabilitie
Deferred tax assets (liabilities) were comprised of the following (Details) (USD $) | 31-May-14 | 31-May-13 |
In Thousands, unless otherwise specified | ||
Deferred tax assets (liabilities) were comprised of the following: | ' | ' |
Net operating loss carryforwards | $7,271 | $7,190 |
Tax credit carryforwards | 254 | 254 |
Receivables allowances | 7 | 11 |
Vacation pay accrual | 9 | 10 |
Other accruals | 0 | 0 |
Depreciation | 37 | 35 |
Differences in book and tax basis of assets of acquired businesses | -859 | -1,050 |
Total gross deferred tax assets | 6,719 | 6,450 |
Valuation allowance. | -6,719 | -6,450 |
Net deferred tax asset | $0 | $0 |
EMPLOYEE_RETIREMENT_PLANS_Deta
EMPLOYEE RETIREMENT PLANS (Details) (USD $) | 12 Months Ended | |
31-May-14 | 31-May-13 | |
EMPLOYEE RETIREMENT PLANS AS FOLLOWS | ' | ' |
Expense related to employer for fiscal years | $51,000 | $46,000 |
SEGMENT_INFORMATION_Details
SEGMENT INFORMATION (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | 31-May-14 | 31-May-13 |
SEGMENT INFORMATION AS FOLLOWS: | ' | ' |
North America Revenue | $3,593 | $4,596 |
Europe Revenue | 493 | 603 |
Asia Revenue | 1,557 | 1,771 |
Eliminations Revenue | -634 | -612 |
Consolidated Revenue Total | $5,009 | $6,358 |
Geographic_location_are_as_fol
Geographic location, are as follows (Details) (USD $) | 31-May-14 | 31-May-13 |
In Thousands, unless otherwise specified | ||
Geographic location, are as follows: | ' | ' |
North America Assets | $1,916 | $5,119 |
Europe Assets | 43 | 113 |
Consolidated Assets Total | $1,959 | $5,232 |
PRIDES_CROSSING_CAPITAL_DETAIL
PRIDES CROSSING CAPITAL (DETAILS) (USD $) | 31-May-14 | Jul. 09, 2013 | 10-May-13 |
PRIDES CROSSING CAPITAL | ' | ' | ' |
Loan Agreement with Prides Crossing Capital L.P. and Prides Crossing Capital -A, L.P. | ' | ' | $2,700,000 |
Loan matures on January 1, 2015 and bears an interest rate of | ' | 14.00% | ' |
Security offered in company's equity interests in its domestic subsidiaries | ' | 100.00% | ' |
Security offered in company's equity interests in its foreign subsidiaries | ' | 65.00% | ' |
Personal guarantee offered by CEO upto | ' | 500,000 | ' |
Repurchase of shares as per the amended agreement | ' | 170,000 | ' |
Warrants issued to the lender | ' | 25,000 | ' |
Exercise price per share | $1 | $1 | ' |
Warrants vesting period | ' | 3 | ' |
Grant date fair value of the warrant of approximately | ' | 51,000 | ' |
Warrant was adjusted to its fair value | 19,000 | ' | ' |
Company agreed to pay down the principal of the Loan | 1,000,000 | ' | ' |
Paid a pre-payment penalty | $81,000 | ' | ' |
Agreed to repurchase the outstanding warrant to purchase shares of common stock | 25,000 | ' | ' |
LEASE_COMMITMENTS_OPERATING_LE
LEASE COMMITMENTS OPERATING LEASES (Details) (USD $) | 12 Months Ended | |
31-May-14 | 31-May-13 | |
LEASE COMMITMENTS OPERATING LEASES: | ' | ' |
Rental expense for fiscal years | $181,000 | $194,000 |
LEASE_COMMITMENTS_CAPITAL_LEAS
LEASE COMMITMENTS CAPITAL LEASES (Details) (USD $) | 31-May-14 |
In Thousands, unless otherwise specified | |
LEASE COMMITMENTS CAPITAL LEASES: | ' |
Minimum annual future lease payments 2015 | $23 |
Minimum annual future lease payments 2016 | 23 |
Minimum annual future lease payments 2017 | 23 |
Minimum annual future lease payments 2018 | 13 |
Minimum annual future lease payments 2019 | 5 |
Minimum annual future lease payments | 87 |
Amount representing interest | -21 |
Present value of minimum lease payments | 66 |
Current. | 19 |
Long Term. | $47 |
Minimum_annual_rental_commitme
Minimum annual rental commitments under noncancellable leases (Details) (USD $) | 31-May-14 |
In Thousands, unless otherwise specified | |
Minimum annual rental commitments under noncancellable leases | ' |
Future minimum lease commitments in 2015 | $133 |
Future minimum lease commitments in 2016 | 133 |
Future minimum lease commitments in 2017 | 110 |
Total future minimum lease commitments | $376 |
Notes_Receivables_details
Notes Receivables (details) (USD $) | 31-May-98 |
Notes Receivables details | ' |
Non interest bearing note extended by CEO related to a stock transaction | $134,000 |
Rights_Agreement_Details
Rights Agreement (Details) (USD $) | Feb. 15, 2012 |
Rights Agreement: | ' |
Dividend declared of one common share purchase right for each outstanding share of common stock par value per share | $0.10 |
Purchase price per share of common stock entitled for each right shares | $5 |
Stock_Purchase_Agreement_DETAI
Stock Purchase Agreement (DETAILS) (USD $) | Aug. 08, 2014 | Jun. 30, 2013 |
Stock purchase agreement Details | ' | ' |
Company purchased shares of common stock from Greenleaf | ' | 170,000 |
Purchase price of common stock issued to Greenleaf | ' | $62,900 |
Price per share of common stock issued to Greenleaf | $0.37 | $0.37 |
Remaining shares as set forth in the Registration Rights Agreement with the option of repurchase | ' | 101,411 |
Company repurchased Greenleaf's remaining shares | 101,411 | ' |
Purchase price of Greenleaf's remaining shares | $37,000 | ' |
Patents_Sales_Transactions_DET
Patents Sales Transactions (DETAILS) (USD $) | Sep. 30, 2012 | Jun. 30, 2012 |
Patents Sales Transactions | ' | ' |
Non-refundable initial royalty payment made | ' | $200,000 |
Patents purchased | ' | 290,000 |
Support services payment | ' | 10,000 |
Share of royalties payable | ' | 30.00% |
Increase in the limit of initial payment | $100,000 | ' |
CADRA_technology_sale_transact
CADRA technology sale transactions (Details) (USD $) | 31-May-14 |
In Thousands, unless otherwise specified | |
CADRA technology sale transactions | ' |
Proceeds from the sale of the CADRA technology | $2,880 |
Fair value of the Holdback Payment and the Earn-Out Payments | 922 |
Liabilities assumed by Mentor related to deferred maintenance obligations | 607 |
Professional fees and other expenses related to the transaction | -448 |
Goodwill allocated to the CADRA product line | -3,305 |
Net book value of equipment transferred in the sale | -7 |
Gain on sale of CADRA product line | $649 |
CADRA_product_line_sale_Detail
CADRA product line sale (Details) (USD $) | Oct. 18, 2013 |
CADRA product line sale | ' |
Aggregate consideration for the CADRA Sale | $3,950,000 |
Amount of consideration paid on the closing date | 2,880,000 |
10% holdback which will be paid on the one year anniversary of the closing date | 320,000 |
Earn-Out Payments of up to an aggregate over the three-year period subsequent to the closing date | $750,000 |
Subsequent_transactions_Detail
Subsequent transactions (Details) (USD $) | Oct. 01, 2014 | Sep. 01, 2014 | Aug. 08, 2014 | Jun. 20, 2014 |
Subsequent transactions | ' | ' | ' | ' |
Under the Share Purchase Agreement Essig's CEO and owner purchased shares of SofTech common stock | ' | ' | ' | 110,000 |
Per share value ofshares issued to CEO and owner | ' | ' | ' | $0.10 |
Value ofshares issued to CEO and owner | ' | ' | ' | $550,000 |
Note issued under promissory note agreement | ' | ' | ' | 750,000 |
Interest rate of note issued under promissory note agreement | 9.50% | ' | ' | 9.50% |
Company entered into an additional short term borrowing arrangement with EssigPR | 300,000 | ' | ' | ' |
EssigPR was awarded stock options to purchase SofTech common stock | 5,000 | ' | ' | ' |
Per share price of optionsawarded to EssigPR | $1 | ' | ' | ' |
Company repurchased shares issued Redeemable Common Stock arrangement | ' | ' | 101,411 | 50,000 |
Shares exchanged for a value in accordance with the terms of those Stock Purchase Agreements | ' | ' | $37,522 | $275,000 |
Per share value ofshares repurchased | ' | ' | $0.37 | ' |
In three transactions Company raised proceeds from the issuance of shares | ' | 250,000 | ' | ' |
In three transactions Company issued number of shares | ' | 50,000 | ' | ' |
In three transactions Company issued number of shares at a per share value | ' | $0.10 | ' | ' |
Per share value of shares issued to accredited investors in separate private placement transactions | ' | $5 | ' | ' |
Term_Note_financial_covenants_
Term Note financial covenants (Details) (USD $) | 31-May-14 |
Term Note financial covenants | ' |
Month-end minimum consolidated cash balance to be established | $1,000,000 |
Amount to be held in the Company's main operating account that is subject to a deposit account control agreement | 750,000 |
Minimum amount of consolidated cash at all times to be maintained | 750,000 |
EBITDA for Q3 and Q4 of fiscal 2014 shall not exceed a loss for each of those fiscal quarters | 200,000 |
EBITDA shall be positive and greater than for each subsequent fiscal quarter. | $100,000 |
Transactions_with_Accredited_I
Transactions with Accredited Investors (Details) (USD $) | Sep. 22, 2014 | Sep. 18, 2014 |
Transactions with Accredited Investors | ' | ' |
Shares issued to Robert Anthonyson | ' | 20,000 |
Value of Shares issued toRobert Anthonyson | ' | $100,000 |
Shares issued to Glenn W. Dillon | 20,000 | ' |
Value of Shares issued to Glenn W. Dillon | 100,000 | ' |
Shares issued to Thomas Doherty | 10,000 | ' |
Value of Shares issued to Thomas Doherty | $50,000 | ' |